Background	Background	NN	0
A	A	DT	0
near-universal	near-universal	JJ	B-NP
feature	feature	NN	I-NP
of	of	IN	0
cell	cell	NN	0
signaling	signaling	VBG	0
via	via	IN	0
seven	seven	CD	0
transmembrane	transmembrane	NN	B-NP
,	,	,	0
G	G	NNP	0
protein-coupled	protein-coupled	JJ	0
receptor	receptor	NN	B-NP
is	is	VBZ	0
cellular	cellular	JJ	B-NP
response	response	NN	I-NP
attenuation	attenuation	VBN	I-NP
upon	upon	IN	0
prolonged	prolonged	JJ	0
exposure	exposure	NN	0
to	to	TO	0
an	an	DT	0
extracellular	extracellular	JJ	B-NP
stimulus	stimulus	NN	I-NP
[	[	-LRB-	0
1	1	LS	0
]	]	-RRB-	0
.	.	.	0
This	This	DT	0
desensitization	desensitization	JJ	B-NP
process	process	NN	I-NP
is	is	VBZ	0
well-established	well-established	JJ	0
for	for	IN	0
GnRH-stimulated	GnRH-stimulated	NNP	B-NP
LH	LH	NNP	I-NP
secretion	secretion	NN	I-NP
from	from	IN	0
pituitary	pituitary	JJ	B-NP
gonadotrope	gonadotrope	NN	I-NP
[	[	-LRB-	0
2	2	CD	0
3	3	CD	0
]	]	-RRB-	0
,	,	,	0
and	and	CC	0
occurs	occurs	VBZ	0
after	after	IN	0
about	about	IN	0
6	6	CD	0
h	h	NN	0
of	of	IN	0
continued	continued	JJ	0
exposure	exposure	NN	0
to	to	TO	0
GnRH	GnRH	JJ	0
in	in	IN	0
rats	rats	NNS	0
[	[	-LRB-	0
3	3	LS	0
]	]	-RRB-	0
;	;	:	0
removal	removal	NN	0
of	of	IN	0
GnRH	GnRH	JJ	B-NP
permit	permit	NN	I-NP
recovery	recovery	NN	I-NP
from	from	IN	0
the	the	DT	0
profound	profound	JJ	0
suppression	suppression	NN	0
of	of	IN	0
LH	LH	NNP	B-NP
secretion	secretion	NN	I-NP
,	,	,	0
albeit	albeit	IN	0
rather	rather	RB	0
slowly	slowly	RB	0
(	(	-LRB-	0
2-4	2-4	CD	0
days	days	NNS	0
;	;	:	0
4	4	LS	0
)	)	-RRB-	0
.	.	.	0
The	The	DT	0
molecular	molecular	JJ	B-NP
mechanism	mechanism	NN	I-NP
involved	involved	VBN	0
in	in	IN	0
GnRH-induced	GnRH-induced	JJ	B-NP
desensitization	desensitization	NN	I-NP
are	are	VBP	0
poorly	poorly	RB	0
understood	understood	VBN	0
,	,	,	0
but	but	CC	0
they	they	PRP	0
do	do	VBP	0
not	not	RB	0
appear	appear	VB	0
to	to	TO	0
be	be	VB	0
due	due	JJ	0
to	to	TO	0
alterations	alterations	VB	0
in	in	IN	0
GnRH	GnRH	JJ	B-NP
receptor	receptor	NN	I-NP
expression	expression	NN	I-NP
[	[	-LRB-	0
5	5	CD	0
6	6	CD	0
]	]	-RRB-	0
or	or	CC	0
to	to	TO	0
changes	changes	NNS	0
in	in	IN	0
lh	lh	NN	B-NP
concentration	concentration	NN	I-NP
in	in	IN	0
the	the	DT	0
pituitary	pituitary	JJ	B-NP
gland	gland	NN	I-NP
[	[	-LRB-	0
7	7	CD	0
8	8	CD	0
]	]	-RRB-	0
.	.	.	0
Earlier	Earlier	RBR	0
,	,	,	0
we	we	PRP	0
presented	presented	VBD	B-NP
evidence	evidence	NN	I-NP
that	that	IN	0
a	a	DT	0
regulator	regulator	NN	0
of	of	IN	0
G	G	NNP	B-NP
protein	protein	NN	I-NP
signaling	signaling	NN	I-NP
,	,	,	0
RGS3	RGS3	NNP	B-NP
,	,	,	0
might	might	MD	0
participate	participate	VB	0
in	in	IN	0
the	the	DT	0
regulation	regulation	NN	0
of	of	IN	0
GnRH	GnRH	JJ	B-NP
receptor	receptor	NN	I-NP
signaling	signaling	NNS	0
[	[	-LRB-	0
9	9	CD	0
]	]	-RRB-	0
.	.	.	0
The	The	DT	0
mechanism	mechanism	NN	0
of	of	IN	0
RGS	RGS	NNP	B-NP
action	action	NN	I-NP
is	is	VBZ	0
antagonism	antagonism	VBN	0
of	of	IN	0
the	the	DT	0
Gα	Gα	JJ	B-NP
protein	protein	NN	I-NP
either	either	CC	0
by	by	IN	0
accelerating	accelerating	VBG	0
its	its	PRP$	0
gtp	gtp	NN	B-NP
hydrolysi	hydrolysi	NN	I-NP
,	,	,	0
thereby	thereby	RB	0
prematurely	prematurely	RB	0
terminating	terminating	VBP	0
signaling	signaling	VBG	0
due	due	JJ	0
to	to	TO	0
reassociation	reassociation	VB	0
of	of	IN	0
the	the	DT	0
Gα	Gα	NNP	B-NP
and	and	CC	0
gβγ	gβγ	NN	B-NP
complex	complex	JJ	I-NP
[	[	-LRB-	0
10	10	CD	0
]	]	-RRB-	0
,	,	,	0
or	or	CC	0
by	by	IN	0
antagonizing	antagonizing	JJ	0
interaction	interaction	NN	0
of	of	IN	0
the	the	DT	0
Gα	Gα	JJ	B-NP
protein	protein	NN	I-NP
with	with	IN	0
its	its	PRP$	0
effector	effector	JJ	0
such	such	JJ	0
as	as	IN	0
phospholipase	phospholipase	JJ	B-NP
Cβ	Cβ	NNP	I-NP
[	[	-LRB-	0
11	11	CD	0
12	12	CD	0
]	]	-RRB-	0
.	.	.	0
A	A	DT	0
large	large	JJ	0
number	number	NN	0
of	of	IN	0
rg	rg	NN	B-NP
gene	gene	NN	I-NP
have	have	VBP	0
been	been	VBN	0
identified	identified	VBN	0
in	in	IN	0
mammals	mammals	VBG	0
based	based	VBN	0
on	on	IN	0
the	the	DT	0
presence	presence	NN	0
of	of	IN	0
a	a	DT	0
120	120	CD	0
amino	amino	JJ	0
acid	acid	NN	B-NP
core	core	NN	I-NP
domain	domain	NN	I-NP
[	[	-LRB-	0
13	13	CD	0
14	14	CD	0
15	15	CD	0
16	16	CD	0
]	]	-RRB-	0
.	.	.	0
rg	rg	NN	B-NP
proteins	proteins	NNS	0
have	have	VBP	0
been	been	VBN	0
described	described	VBN	0
that	that	IN	0
interact	interact	NN	0
with	with	IN	0
the	the	DT	0
G	G	NNP	0
i	i	FW	0
α	α	FW	0
and	and	CC	0
g	g	NN	B-NP
protein	protein	NN	I-NP
family	family	NN	I-NP
g	g	NN	I-NP
qα	qα	NN	I-NP
member	member	NN	I-NP
[	[	-LRB-	0
17	17	CD	0
18	18	CD	0
19	19	CD	0
20	20	CD	0
21	21	CD	0
]	]	-RRB-	0
.	.	.	0
Previously	Previously	RB	0
,	,	,	0
we	we	PRP	0
showed	showed	VBD	0
that	that	IN	0
RSG3	RSG3	NNP	B-NP
was	was	VBD	0
expressed	expressed	VBN	0
endogenously	endogenously	VBN	0
in	in	IN	0
rat	rat	JJ	0
pituitary	pituitary	JJ	B-NP
cell	cell	NN	I-NP
and	and	CC	0
,	,	,	0
when	when	WRB	0
experimentally	experimentally	JJ	0
co-expressed	co-expressed	NN	0
together	together	RB	0
with	with	IN	0
gnrh	gnrh	NN	B-NP
receptor	receptor	NN	I-NP
in	in	IN	0
a	a	DT	0
heterologous	heterologous	JJ	B-NP
cell	cell	NN	I-NP
line	line	NN	I-NP
(	(	-LRB-	0
COS1	COS1	NNP	B-NP
)	)	-RRB-	0
,	,	,	0
it	it	PRP	0
suppressed	suppressed	VBD	B-NP
GnRH-stimulated	GnRH-stimulated	JJ	I-NP
inositol	inositol	JJ	I-NP
trisphosphate	trisphosphate	JJ	I-NP
production	production	NN	I-NP
[	[	-LRB-	0
9	9	CD	0
]	]	-RRB-	0
.	.	.	0
Here	Here	RB	0
,	,	,	0
those	those	DT	0
studies	studies	NNS	0
have	have	VBP	0
been	been	VBN	0
extended	extended	VBN	0
to	to	TO	0
include	include	VB	0
GnRH-stimulated	GnRH-stimulated	JJ	B-NP
LH	LH	NN	I-NP
secretion	secretion	VBP	I-NP
using	using	VBG	0
rgs3	rgs3	NN	B-NP
complementary	complementary	JJ	I-NP
dna	dna	NN	I-NP
adenovirus-mediated	adenovirus-mediated	JJ	I-NP
gene	gene	NN	I-NP
transfer	transfer	NN	I-NP
into	into	IN	0
normal	normal	JJ	B-NP
rat	rat	NN	I-NP
pituitary	pituitary	NN	I-NP
gonadotrope	gonadotrope	NN	I-NP
.	.	.	0
RGS3	RGS3	NNP	B-NP
was	was	VBD	0
found	found	VBN	0
to	to	TO	0
profoundly	profoundly	RB	0
inhibit	inhibit	VB	0
GnRH-stimulated	GnRH-stimulated	JJ	B-NP
LH	LH	NNP	I-NP
secretion	secretion	NN	I-NP
and	and	CC	0
3H-inositol	3H-inositol	CD	0
phosphate	phosphate	JJ	0
accumulation	accumulation	NN	0
.	.	.	0
However	However	RB	0
,	,	,	0
a	a	DT	0
stimulated	stimulated	VBN	B-NP
lh	lh	NN	I-NP
secretion	secretion	NN	I-NP
calcium	calcium	NN	I-NP
ionophore	ionophore	NN	I-NP
in	in	FW	0
rgs3-expressing	rgs3-expressing	NN	B-NP
gonadotrope	gonadotrope	NN	I-NP
,	,	,	0
confirming	confirming	VBG	0
a	a	DT	0
specific	specific	JJ	0
site	site	NN	0
of	of	IN	0
action	action	NN	0
occurring	occurring	VBG	0
at	at	IN	0
phospholipase	phospholipase	JJ	B-NP
Cβ	Cβ	NNP	I-NP
or	or	CC	0
earlier	earlier	RBR	0
in	in	IN	0
the	the	DT	0
signal	signal	NN	B-NP
transduction	transduction	NN	I-NP
pathway	pathway	NN	I-NP
.	.	.	0
Results	Results	NNS	0
The	The	DT	0
initial	initial	JJ	0
experiments	experiments	NNS	0
were	were	VBD	0
performed	performed	VBN	0
to	to	TO	0
confirm	confirm	VB	0
our	our	PRP$	0
earlier	earlier	JJR	0
finding	finding	NN	0
that	that	IN	0
suppressed	suppressed	VBD	B-NP
gnrh-stimulated	gnrh-stimulated	NN	I-NP
ip	ip	NNP	I-NP
rgs3	rgs3	NN	I-NP
3	3	CD	0
production	production	NN	0
in	in	IN	0
cos-1	cos-1	NN	B-NP
cell	cell	NN	I-NP
[	[	-LRB-	0
9	9	CD	0
]	]	-RRB-	0
and	and	CC	0
to	to	TO	0
test	test	VB	0
a	a	DT	0
truncated	truncated	JJ	0
form	form	NN	0
of	of	IN	0
RGS3	RGS3	NNP	B-NP
,	,	,	0
RGS3T	RGS3T	NNP	0
(	(	-LRB-	0
RGS3	RGS3	NNP	B-NP
314-519	314-519	NNP	0
)	)	-RRB-	0
[	[	-LRB-	0
24	24	CD	0
]	]	-RRB-	0
for	for	IN	0
suppressive	suppressive	JJ	B-NP
activity	activity	NN	I-NP
in	in	IN	0
the	the	DT	0
same	same	JJ	0
assay	assay	NN	B-NP
(	(	-LRB-	0
Fig.	Fig.	CD	0
1	1	CD	0
)	)	-RRB-	0
.	.	.	0
cDNAs	cDNAs	JJ	0
representing	representing	VBG	0
the	the	DT	0
GnRH	GnRH	JJ	B-NP
receptor	receptor	NN	I-NP
and	and	CC	0
RGS3	RGS3	NNP	B-NP
or	or	CC	0
RGS3T	RGS3T	NNP	0
were	were	VBD	0
co-transfected	co-transfected	JJ	B-NP
into	into	IN	0
gnrh-a	gnrh-a	NN	B-NP
treatment	treatment	NN	I-NP
cos-1	cos-1	NN	I-NP
cell	cell	NN	I-NP
72	72	CD	0
h	h	NNS	0
later	later	RB	0
;	;	:	0
intracellular	intracellular	JJ	B-NP
IP	IP	NNP	I-NP
3	3	CD	0
concentration	concentration	NN	B-NP
were	were	VBD	0
measured	measured	VBN	0
at	at	IN	0
0	0	CD	0
,	,	,	0
10	10	CD	0
,	,	,	0
20	20	CD	0
,	,	,	0
and	and	CC	0
30	30	CD	0
sec	sec	NN	0
after	after	IN	0
addition	addition	NN	B-NP
of	of	IN	0
10	10	CD	0
-7M	-7M	CD	0
GnRH-A	GnRH-A	NNS	0
(	(	-LRB-	0
Fig.	Fig.	CD	0
1	1	CD	0
)	)	-RRB-	0
.	.	.	0
As	As	RB	0
expected	expected	VBN	0
,	,	,	0
RGS3	RGS3	NNP	B-NP
exerted	exerted	VBD	0
a	a	DT	0
profound	profound	JJ	0
suppression	suppression	NN	0
of	of	IN	0
IP	IP	NNP	B-NP
3	3	CD	0
production	production	NN	0
at	at	IN	0
each	each	DT	0
of	of	IN	0
the	the	DT	0
time	time	NN	B-NP
point	point	NN	I-NP
during	during	IN	0
the	the	DT	0
30	30	CD	0
sec	sec	NN	0
after	after	IN	0
agonist	agonist	JJ	B-NP
treatment	treatment	NN	I-NP
(	(	-LRB-	0
p	p	CD	0
<	<	SYM	0
0.05	0.05	CD	0
)	)	-RRB-	0
(	(	-LRB-	0
Fig.	Fig.	CD	0
1	1	CD	0
)	)	-RRB-	0
.	.	.	0
RGS3T	RGS3T	NNP	0
is	is	VBZ	0
comprised	comprised	VBN	0
primarily	primarily	RB	0
by	by	IN	0
the	the	DT	0
consensus	consensus	NN	B-NP
RGS	RGS	NNP	I-NP
domain	domain	NN	I-NP
and	and	CC	0
was	was	VBD	0
originally	originally	RB	0
reported	reported	VBN	0
to	to	TO	0
decrease	decrease	VB	0
the	the	DT	0
growth	growth	NN	B-NP
rate	rate	NN	I-NP
of	of	IN	0
yeast	yeast	NN	0
and	and	CC	0
to	to	TO	0
inhibit	inhibit	VB	0
map	map	NN	B-NP
kinase	kinase	NN	I-NP
il-8	il-8	NN	I-NP
receptor	receptor	NN	I-NP
mediated	mediated	NN	I-NP
activation	activation	NN	I-NP
by	by	IN	0
a	a	DT	0
factor	factor	NN	B-NP
of	of	IN	0
3-10	3-10	NNP	0
fold	fold	VBP	0
as	as	RB	0
compared	compared	VBN	0
to	to	TO	0
RGS3	RGS3	CD	B-NP
[	[	-LRB-	0
24	24	CD	0
]	]	-RRB-	0
and	and	CC	0
was	was	VBD	0
subsequently	subsequently	RB	0
reported	reported	VBN	0
to	to	TO	0
be	be	VB	0
a	a	DT	0
normally	normally	RB	0
rgs3	rgs3	NN	B-NP
expressed	expressed	VBD	I-NP
variant	variant	VBN	I-NP
[	[	-LRB-	0
37	37	CD	0
]	]	-RRB-	0
.	.	.	0
Therefore	Therefore	RB	0
,	,	,	0
we	we	PRP	0
compared	compared	VBD	0
it	it	PRP	0
to	to	TO	0
gnrh-stimulated	gnrh-stimulated	NN	B-NP
ip	ip	NNP	I-NP
attenuation	attenuation	NN	I-NP
rgs3	rgs3	NN	I-NP
3	3	CD	0
production	production	NN	0
in	in	IN	0
cos-1	cos-1	NN	B-NP
cell	cell	NN	I-NP
(	(	-LRB-	0
Fig.	Fig.	CD	0
1	1	CD	0
)	)	-RRB-	0
.	.	.	0
As	As	RB	0
reported	reported	VBN	0
by	by	IN	0
others	others	NNS	0
[	[	-LRB-	0
24	24	CD	0
37	37	CD	0
]	]	-RRB-	0
,	,	,	0
we	we	PRP	0
found	found	VBD	0
that	that	IN	0
RGS3T	RGS3T	NNP	0
was	was	VBD	0
more	more	RBR	0
potent	potent	JJ	0
than	than	IN	0
RGS3	RGS3	NNP	B-NP
(	(	-LRB-	0
p	p	CD	0
<	<	SYM	0
0.05	0.05	CD	0
)	)	-RRB-	0
(	(	-LRB-	0
Fig.	Fig.	CD	0
1	1	CD	0
)	)	-RRB-	0
.	.	.	0
c-terminal	c-terminal	NN	B-NP
identification	identification	NN	I-NP
205	205	CD	0
amino	amino	JJ	0
rgs3	rgs3	NN	B-NP
acid	acid	NN	I-NP
variant	variant	NN	I-NP
that	that	WDT	0
has	has	VBZ	0
equal	equal	JJ	0
or	or	CC	0
greater	greater	JJR	0
potency	potency	NN	0
than	than	IN	0
the	the	DT	0
full-length	full-length	JJ	0
519	519	CD	0
amino	amino	JJ	0
acid	acid	NN	B-NP
RGS3	RGS3	NN	I-NP
will	will	MD	0
facilitate	facilitate	VB	0
the	the	DT	0
rgs3	rgs3	NN	B-NP
functional	functional	JJ	I-NP
protein	protein	NN	I-NP
domain	domain	NN	I-NP
identification	identification	NN	I-NP
that	that	WDT	0
are	are	VBP	0
important	important	JJ	0
for	for	IN	0
its	its	PRP$	0
activity	activity	NN	0
.	.	.	0
The	The	DT	0
family	family	NN	0
of	of	IN	0
rg	rg	NN	B-NP
proteins	proteins	NNS	0
are	are	VBP	0
established	established	VBN	0
to	to	TO	0
interact	interact	VB	0
with	with	IN	0
various	various	JJ	0
gα-protein	gα-protein	NN	B-NP
subunit	subunit	NN	I-NP
,	,	,	0
thereby	thereby	RB	0
antagonizing	antagonizing	VB	0
their	their	PRP$	0
activities	activities	NNS	0
[	[	-LRB-	0
13	13	CD	0
14	14	CD	0
15	15	CD	0
16	16	CD	0
17	17	CD	0
18	18	CD	0
24	24	CD	0
]	]	-RRB-	0
.	.	.	0
Indeed	Indeed	RB	0
,	,	,	0
we	we	PRP	0
previously	previously	RB	0
reported	reported	VBN	0
that	that	IN	0
RGS3	RGS3	NN	B-NP
bound	bound	JJ	I-NP
Gqα	Gqα	NN	I-NP
[	[	-LRB-	0
9	9	CD	0
]	]	-RRB-	0
,	,	,	0
the	the	DT	0
G	G	NNP	B-NP
protein	protein	NN	I-NP
subunit	subunit	NN	I-NP
that	that	IN	0
mediates	mediates	JJ	0
GnRH	GnRH	JJ	B-NP
receptor	receptor	NN	I-NP
signaling	signaling	NNS	0
[	[	-LRB-	0
38	38	CD	0
]	]	-RRB-	0
.	.	.	0
Here	Here	RB	0
,	,	,	0
we	we	PRP	0
have	have	VBP	0
extended	extended	VBN	0
those	those	DT	0
binding	binding	JJ	0
studies	studies	NNS	0
to	to	TO	0
include	include	VB	0
other	other	JJ	0
gα	gα	NN	B-NP
protein	protein	NN	I-NP
(	(	-LRB-	0
Fig.	Fig.	CD	0
2	2	CD	0
)	)	-RRB-	0
.	.	.	0
An	An	DT	0
RGS3-GST	RGS3-GST	JJ	B-NP
fusion	fusion	NN	I-NP
protein	protein	NN	I-NP
was	was	VBD	0
incubated	incubated	VBN	0
with	with	IN	0
an	an	DT	0
35S-Met-Gα-protein	35S-Met-Gα-protein	NNP	0
,	,	,	0
and	and	CC	0
the	the	DT	0
amount	amount	NN	0
of	of	IN	0
labeled	labeled	JJ	0
Gα-protein	Gα-protein	NN	B-NP
was	was	VBD	0
determined	determined	VBN	0
using	using	VBG	0
glutathione-coupled	glutathione-coupled	JJ	B-NP
bead	bead	NN	I-NP
to	to	TO	0
"pull	"pull	CD	0
down	down	IN	0
"	"	``	0
the	the	DT	0
RGS3-GST	RGS3-GST	CD	B-NP
/	/	CD	0
35S-Gα-protein	35S-Gα-protein	CD	0
complex	complex	NN	0
that	that	WDT	0
was	was	VBD	0
then	then	RB	0
separated	separated	VBN	0
and	and	CC	0
quantified	quantified	VBN	0
by	by	IN	0
SDS	SDS	NNP	B-NP
/	/	NNP	I-NP
PAGE	PAGE	NNP	I-NP
(	(	-LRB-	0
Fig.	Fig.	CD	0
2	2	CD	0
)	)	-RRB-	0
.	.	.	0
More	More	JJR	0
Gqα	Gqα	NNP	B-NP
was	was	VBD	0
bound	bound	VBN	0
by	by	IN	0
RGS3	RGS3	CD	B-NP
than	than	IN	0
any	any	DT	0
other	other	JJ	0
protein	protein	NN	B-NP
,	,	,	0
although	although	IN	0
its	its	PRP$	0
binding	binding	NN	0
was	was	VBD	0
not	not	RB	0
significantly	significantly	RB	0
different	different	JJ	0
from	from	IN	0
that	that	DT	0
of	of	IN	0
Gzα	Gzα	NNP	B-NP
and	and	CC	0
Giα	Giα	NNP	B-NP
(	(	-LRB-	0
p	p	CD	0
>	>	CD	0
0.05	0.05	CD	0
)	)	-RRB-	0
.	.	.	0
Significant	Significant	JJ	0
(	(	-LRB-	0
p	p	CD	0
<	<	SYM	0
0.05	0.05	CD	0
)	)	-RRB-	0
amounts	amounts	NNS	0
of	of	IN	0
Gi2α	Gi2α	NNP	B-NP
,	,	,	0
Gi1α	Gi1α	NNP	B-NP
,	,	,	0
Goα	Goα	NNP	B-NP
,	,	,	0
and	and	CC	0
Gsα	Gsα	NNP	B-NP
also	also	RB	0
were	were	VBD	0
bound	bound	VBN	0
but	but	CC	0
were	were	VBD	0
not	not	RB	0
as	as	IN	0
high	high	JJ	0
as	as	IN	0
Gqα	Gqα	NNP	B-NP
,	,	,	0
Gzα	Gzα	NNP	B-NP
,	,	,	0
and	and	CC	0
Gi3α	Gi3α	NNP	B-NP
.	.	.	0
These	These	DT	0
results	results	NNS	0
confirm	confirm	VBP	0
our	our	PRP$	0
previous	previous	JJ	0
findings	findings	NNS	0
that	that	IN	0
RGS3	RGS3	CD	B-NP
interacts	interacts	NN	0
with	with	IN	0
Gqα	Gqα	NNP	B-NP
but	but	CC	0
also	also	RB	0
show	show	VB	0
that	that	IN	0
it	it	PRP	0
has	has	VBZ	0
significant	significant	JJ	0
interaction	interaction	NN	0
with	with	IN	0
all	all	DT	0
other	other	JJ	0
Gα-proteins	Gα-proteins	JJ	B-NP
studied	studied	NN	I-NP
.	.	.	0
The	The	DT	0
findings	findings	NNS	0
of	of	IN	0
the	the	DT	0
current	current	JJ	0
,	,	,	0
and	and	CC	0
an	an	DT	0
earlier	earlier	JJR	0
study	study	NN	0
[	[	-LRB-	0
9	9	CD	0
]	]	-RRB-	0
,	,	,	0
demonstrate	demonstrate	VBP	0
clearly	clearly	RB	0
that	that	IN	0
RGS3	RGS3	CD	B-NP
suppresses	suppresses	CD	0
GnRH	GnRH	JJ	B-NP
receptor	receptor	NN	I-NP
signaling	signaling	VBG	0
in	in	IN	0
a	a	DT	0
heterologous	heterologous	JJ	B-NP
cell	cell	NN	I-NP
system	system	NN	I-NP
.	.	.	0
Because	Because	IN	0
of	of	IN	0
the	the	DT	0
evidence	evidence	NN	0
that	that	IN	0
the	the	DT	0
signal	signal	NN	B-NP
transduction	transduction	NN	I-NP
pathway	pathway	NN	I-NP
for	for	IN	0
GnRH	GnRH	JJ	0
in	in	IN	0
gonadotrope	gonadotrope	NN	B-NP
involves	involves	VBZ	0
the	the	DT	0
GnRH	GnRH	JJ	B-NP
receptor	receptor	NN	I-NP
,	,	,	0
Gqα	Gqα	NNP	B-NP
,	,	,	0
phospholipase	phospholipase	VBG	0
Cβ	Cβ	NNP	B-NP
,	,	,	0
and	and	CC	0
cellular	cellular	JJ	B-NP
IP	IP	NNP	I-NP
3	3	CD	0
release	release	NN	0
[	[	-LRB-	0
39	39	CD	0
40	40	CD	0
]	]	-RRB-	0
,	,	,	0
we	we	PRP	0
determined	determined	VBD	0
the	the	DT	0
effect	effect	NN	0
of	of	IN	0
RGS3	RGS3	CD	B-NP
on	on	IN	0
GnRH-stimulated	GnRH-stimulated	NNP	B-NP
LH	LH	NNP	I-NP
secretion	secretion	VBZ	I-NP
using	using	VBG	0
adenoviral-mediated	adenoviral-mediated	JJ	B-NP
gene	gene	NN	I-NP
transfer	transfer	NN	I-NP
in	in	IN	0
rat	rat	JJ	0
pituitary	pituitary	JJ	B-NP
cell	cell	NN	I-NP
(	(	-LRB-	0
Fig.	Fig.	CD	0
3	3	CD	0
)	)	-RRB-	0
.	.	.	0
In	In	IN	0
these	these	DT	0
experiments	experiments	NNS	0
,	,	,	0
we	we	PRP	0
performed	performed	VBD	0
a	a	DT	0
dose-response	dose-response	JJ	B-NP
test	test	NN	I-NP
that	that	WDT	0
included	included	VBD	0
three	three	CD	0
experimental	experimental	JJ	B-NP
group	group	NN	I-NP
:	:	:	0
uninfected	uninfected	CD	B-NP
,	,	,	0
adeno-β	adeno-β	JJ	B-NP
galactosidase	galactosidase	NN	I-NP
,	,	,	0
and	and	CC	0
adeno-RGS3	adeno-RGS3	CD	B-NP
infected	infected	NNS	0
.	.	.	0
Adeno-βgal	Adeno-βgal	JJ	B-NP
infection	infection	NN	I-NP
was	was	VBD	0
used	used	VBN	0
for	for	IN	0
fraction	fraction	NN	B-NP
determination	determination	NN	I-NP
of	of	IN	0
cells	cells	NNS	0
infected	infected	VBN	0
at	at	IN	0
each	each	DT	0
dose	dose	NN	0
of	of	IN	0
virus	virus	NN	0
(	(	-LRB-	0
Fig.	Fig.	CD	0
3	3	CD	0
,	,	,	0
top	top	JJ	0
panel	panel	NN	0
)	)	-RRB-	0
and	and	CC	0
as	as	IN	0
a	a	DT	0
control	control	NN	0
for	for	IN	0
the	the	DT	0
effects	effects	NNS	0
of	of	IN	0
adeno-RGS3	adeno-RGS3	CD	B-NP
on	on	IN	0
GnRH-stimulated	GnRH-stimulated	NNP	B-NP
LH	LH	NNP	I-NP
secretion	secretion	NN	I-NP
(	(	-LRB-	0
Fig.	Fig.	CD	0
3	3	CD	0
,	,	,	0
middle	middle	JJ	0
panel	panel	NN	0
)	)	-RRB-	0
.	.	.	0
Cell	Cell	NN	0
viability	viability	NN	0
,	,	,	0
measured	measured	VBN	0
as	as	IN	0
trypan	trypan	JJ	B-NP
blue	blue	JJ	I-NP
exclusion	exclusion	NN	I-NP
,	,	,	0
varied	varied	VBN	0
from	from	IN	0
98.5-100.0	98.5-100.0	CD	0
%	%	NN	0
(	(	-LRB-	0
Fig.	Fig.	CD	0
3	3	CD	0
,	,	,	0
top	top	JJ	0
panel	panel	NN	0
)	)	-RRB-	0
.	.	.	0
The	The	DT	0
fraction	fraction	NN	B-NP
of	of	IN	0
cells	cells	NNS	0
infected	infected	VBN	0
by	by	IN	0
the	the	DT	0
adenovirus	adenovirus	NN	B-NP
depended	depended	VBD	0
on	on	IN	0
viral	viral	JJ	B-NP
dose	dose	NN	I-NP
(	(	-LRB-	0
0-5.0	0-5.0	NNP	0
M.O.I.	M.O.I.	NNP	B-NP
;	;	:	0
1	1	CD	0
M.O.I.	M.O.I.	CD	B-NP
=	=	SYM	0
1	1	CD	0
viral	viral	JJ	B-NP
particle	particle	NN	I-NP
/	/	NN	I-NP
pituitary	pituitary	JJ	I-NP
cell	cell	NN	I-NP
)	)	-RRB-	0
and	and	CC	0
ranged	ranged	VBD	0
from	from	IN	0
about	about	IN	0
2	2	CD	0
%	%	NN	0
(	(	-LRB-	0
no	no	UH	0
adenovirus	adenovirus	UH	B-NP
)	)	-RRB-	0
to	to	TO	0
99.5	99.5	CD	0
%	%	NN	0
(	(	-LRB-	0
5.0	5.0	CD	0
M.O.I.	M.O.I.	CD	B-NP
)	)	-RRB-	0
.	.	.	0
Adeno-βgal	Adeno-βgal	NNP	B-NP
had	had	VBD	0
no	no	DT	0
effect	effect	NN	0
on	on	IN	0
LH	LH	NNP	B-NP
secretion	secretion	NN	I-NP
at	at	IN	0
any	any	DT	0
dose	dose	NN	0
compared	compared	VBN	0
to	to	TO	0
the	the	DT	0
uninfected	uninfected	JJ	B-NP
group	group	NN	I-NP
(	(	-LRB-	0
Fig.	Fig.	CD	0
3	3	CD	0
,	,	,	0
middle	middle	JJ	0
panel	panel	NN	0
)	)	-RRB-	0
.	.	.	0
In	In	IN	0
contrast	contrast	NN	0
,	,	,	0
an	an	DT	0
inverse	inverse	JJ	B-NP
dose-related	dose-related	JJ	0
effect	effect	NN	0
was	was	VBD	0
observed	observed	VBN	0
between	between	IN	0
adeno-RGS3	adeno-RGS3	NNP	B-NP
and	and	CC	0
GnRH-stimulated	GnRH-stimulated	NNP	B-NP
LH	LH	NNP	I-NP
secretion	secretion	NN	I-NP
(	(	-LRB-	0
Fig.	Fig.	CD	0
3	3	CD	0
,	,	,	0
bottom	bottom	JJ	0
panel	panel	NN	0
)	)	-RRB-	0
.	.	.	0
RGS3	RGS3	CD	B-NP
0.2	0.2	CD	0
M.O.I.	M.O.I.	CD	B-NP
was	was	VBD	0
the	the	DT	0
lowest	lowest	JJS	0
dose	dose	NN	0
to	to	TO	0
inhibit	inhibit	VB	0
LH	LH	JJ	B-NP
secretion	secretion	NN	I-NP
(	(	-LRB-	0
p	p	CD	0
<	<	SYM	0
0.05	0.05	CD	0
)	)	-RRB-	0
,	,	,	0
and	and	CC	0
2.0	2.0	CD	0
and	and	CC	0
5.0	5.0	CD	0
M.O.I.	M.O.I.	CD	B-NP
exerted	exerted	NN	0
near	near	IN	0
complete	complete	JJ	0
inhibition	inhibition	NN	0
of	of	IN	0
LH	LH	NNP	B-NP
secretion	secretion	NN	I-NP
;	;	:	0
i.e.	i.e.	FW	0
lh	lh	NN	B-NP
concentration	concentration	NN	I-NP
in	in	IN	0
these	these	DT	0
two	two	CD	0
latter	latter	JJ	0
gnrh-treated	gnrh-treated	NN	B-NP
group	group	NN	I-NP
did	did	VBD	0
not	not	RB	0
differ	differ	VB	0
from	from	IN	0
their	their	PRP$	0
cohort	cohort	JJ	B-NP
control	control	NN	I-NP
(	(	-LRB-	0
p	p	CD	0
>	>	CD	0
0.05	0.05	CD	0
)	)	-RRB-	0
.	.	.	0
The	The	DT	0
profound	profound	JJ	0
inhibition	inhibition	NN	0
of	of	IN	0
GnRH-stimulated	GnRH-stimulated	NNP	B-NP
LH	LH	NNP	I-NP
secretion	secretion	VBD	I-NP
observed	observed	VBN	0
in	in	IN	0
Fig.	Fig.	CD	0
3required	3required	CD	0
verification	verification	NN	0
that	that	IN	0
RGS3	RGS3	CD	B-NP
expression	expression	NN	I-NP
was	was	VBD	0
induced	induced	VBN	0
by	by	IN	0
adeno-RGS3	adeno-RGS3	CD	B-NP
infection	infection	NN	I-NP
.	.	.	0
To	To	TO	0
address	address	VB	0
this	this	DT	0
issue	issue	NN	0
,	,	,	0
we	we	PRP	0
performed	performed	VBD	B-NP
rgs3	rgs3	NN	I-NP
immunoblot	immunoblot	NN	I-NP
(	(	-LRB-	0
Fig.	Fig.	CD	0
4	4	CD	0
)	)	-RRB-	0
which	which	WDT	0
showed	showed	VBD	0
an	an	DT	0
increase	increase	NN	0
in	in	IN	0
RGS3	RGS3	CD	B-NP
protein	protein	NN	I-NP
expression	expression	NN	I-NP
in	in	IN	0
adeno-RGS3	adeno-RGS3	NNP	B-NP
(	(	-LRB-	0
5.0	5.0	CD	0
M.O.I.	M.O.I.	CD	B-NP
)	)	-RRB-	0
infected	infected	JJ	0
pituitary	pituitary	JJ	B-NP
cell	cell	NN	I-NP
as	as	RB	0
compared	compared	VBN	0
to	to	TO	0
low	low	JJ	0
to	to	TO	0
negligible	negligible	JJ	0
levels	levels	NNS	0
of	of	IN	0
protein	protein	NN	B-NP
in	in	IN	0
the	the	DT	0
uninfected	uninfected	NN	B-NP
and	and	CC	0
adeno-βgal	adeno-βgal	JJ	B-NP
infected	infected	JJ	0
groups	groups	NNS	0
.	.	.	0
As	As	RB	0
evidenced	evidenced	VBN	0
earlier	earlier	RBR	0
,	,	,	0
the	the	DT	0
protein	protein	NN	B-NP
action	action	NN	I-NP
rg	rg	NN	I-NP
molecular	molecular	JJ	I-NP
locus	locus	NN	I-NP
is	is	VBZ	0
thought	thought	VBN	0
to	to	TO	0
be	be	VB	0
the	the	DT	0
G	G	NNP	0
protein	protein	FW	0
α	α	FW	0
subunit	subunit	FW	0
,	,	,	0
specifically	specifically	RB	0
Gqα	Gqα	JJ	0
in	in	IN	0
the	the	DT	0
case	case	NN	0
of	of	IN	0
GnRH	GnRH	JJ	B-NP
receptor	receptor	NN	I-NP
activation	activation	NN	I-NP
.	.	.	0
The	The	DT	0
results	results	NNS	0
shown	shown	VBN	0
in	in	IN	0
Fig.	Fig.	CD	0
5are	5are	CD	0
consistent	consistent	JJ	0
with	with	IN	0
this	this	DT	0
conclusion	conclusion	NN	0
:	:	:	0
adeno-RGS3	adeno-RGS3	CD	B-NP
infection	infection	NN	I-NP
of	of	IN	0
rat	rat	FW	0
pituitary	pituitary	FW	0
cells	cells	FW	0
profoundly	profoundly	FW	0
suppressed	suppressed	FW	0
GnRH-stimulated	GnRH-stimulated	FW	0
3H-inositol	3H-inositol	FW	0
phosphate	phosphate	FW	0
accumulation	accumulation	FW	0
.	.	.	0
These	These	DT	0
results	results	NNS	0
are	are	VBP	0
compatible	compatible	JJ	0
with	with	IN	0
a	a	DT	0
molecular	molecular	JJ	B-NP
site	site	NN	I-NP
of	of	IN	0
action	action	NN	0
for	for	IN	0
RGS3	RGS3	CD	B-NP
being	being	VBG	0
at	at	IN	0
phospholipase	phospholipase	JJ	0
C	C	NNP	0
or	or	CC	0
earlier	earlier	RBR	0
in	in	IN	0
the	the	DT	0
signal	signal	NN	B-NP
transduction	transduction	NN	I-NP
pathway	pathway	NN	I-NP
.	.	.	0
Another	Another	DT	0
experiment	experiment	NN	0
conducted	conducted	VBN	0
to	to	TO	0
test	test	VB	0
the	the	DT	0
specificity	specificity	NN	0
and	and	CC	0
rgs3	rgs3	NN	B-NP
action	action	NN	I-NP
molecular	molecular	JJ	I-NP
locus	locus	NN	I-NP
in	in	IN	0
inhibiting	inhibiting	JJ	0
GnRH-stimulated	GnRH-stimulated	JJ	B-NP
LH	LH	NNP	I-NP
secretion	secretion	NN	I-NP
was	was	VBD	0
treatment	treatment	NN	0
of	of	IN	0
adeno-RGS3	adeno-RGS3	CD	B-NP
infected	infected	JJ	0
cells	cells	NNS	0
with	with	IN	0
an	an	DT	0
agent	agent	NN	B-NP
that	that	WDT	0
increases	increases	VBZ	0
intracellular	intracellular	JJ	B-NP
calcium	calcium	NN	I-NP
(	(	-LRB-	0
Fig.	Fig.	CD	0
6	6	CD	0
)	)	-RRB-	0
.	.	.	0
Calcium	Calcium	NNP	B-NP
is	is	VBZ	0
an	an	DT	0
established	established	JJ	0
lh	lh	NN	B-NP
secretion	secretion	NN	I-NP
stimulator	stimulator	NN	I-NP
that	that	WDT	0
is	is	VBZ	0
thought	thought	VBN	0
to	to	TO	0
act	act	VB	0
at	at	IN	0
sites	sites	NNS	0
downstream	downstream	VBN	0
of	of	IN	0
phospholipase	phospholipase	JJ	0
C	C	NNP	0
[	[	-LRB-	0
39	39	CD	0
40	40	CD	0
]	]	-RRB-	0
.	.	.	0
Therefore	Therefore	RB	0
,	,	,	0
adeno-RGS3	adeno-RGS3	CD	B-NP
infected	infected	JJ	0
pituitary	pituitary	JJ	B-NP
cell	cell	NN	I-NP
were	were	VBD	0
treated	treated	VBN	0
with	with	IN	0
a	a	DT	0
calcium	calcium	JJ	B-NP
ionophora	ionophora	NN	I-NP
(	(	-LRB-	0
A23187	A23187	NNP	0
)	)	-RRB-	0
.	.	.	0
inhibited	inhibited	VBD	B-NP
lh	lh	NN	I-NP
secretion	secretion	NN	I-NP
adeno-rsg3	adeno-rsg3	NN	I-NP
in	in	IN	0
the	the	DT	0
GnRH-treated	GnRH-treated	JJ	B-NP
control	control	NN	I-NP
group	group	NN	I-NP
as	as	IN	0
expected	expected	VBN	0
(	(	-LRB-	0
Fig.	Fig.	CD	0
6	6	CD	0
)	)	-RRB-	0
.	.	.	0
However	However	RB	0
,	,	,	0
the	the	DT	0
stimulated	stimulated	VBN	B-NP
lh	lh	NN	I-NP
secretion	secretion	NN	I-NP
calcium	calcium	NN	I-NP
ionphore	ionphore	NN	I-NP
in	in	FW	0
rgs3-expressing	rgs3-expressing	NN	B-NP
gonadotrope	gonadotrope	NN	I-NP
(	(	-LRB-	0
Fig.	Fig.	CD	0
6	6	CD	0
)	)	-RRB-	0
,	,	,	0
an	an	DT	0
effect	effect	NN	0
that	that	WDT	0
would	would	MD	0
be	be	VB	0
expected	expected	VBN	0
if	if	IN	0
the	the	DT	0
RGS3	RGS3	CD	B-NP
inhibition	inhibition	NN	I-NP
was	was	VBD	0
exerted	exerted	VBN	0
at	at	IN	0
the	the	DT	0
level	level	NN	0
of	of	IN	0
the	the	DT	0
Gqα	Gqα	JJ	B-NP
protein	protein	NN	I-NP
.	.	.	0
In	In	IN	0
two	two	CD	0
final	final	JJ	B-NP
control	control	NN	I-NP
study	study	NN	I-NP
,	,	,	0
we	we	PRP	0
investigated	investigated	VBD	0
the	the	DT	0
effect	effect	NN	0
of	of	IN	0
adeno-RGS3	adeno-RGS3	CD	B-NP
on	on	IN	0
lh	lh	NN	B-NP
concentration	concentration	NN	I-NP
in	in	IN	0
pituitary	pituitary	JJ	B-NP
cell	cell	NN	I-NP
and	and	CC	0
on	on	IN	0
GnRH	GnRH	JJ	B-NP
receptor	receptor	NN	I-NP
binding	binding	NNS	0
(	(	-LRB-	0
Fig.	Fig.	CD	0
7	7	CD	0
)	)	-RRB-	0
.	.	.	0
In	In	IN	0
neither	neither	DT	0
case	case	NN	0
did	did	VBD	0
RGS3	RGS3	RB	0
affect	affect	VB	0
these	these	DT	0
parameters	parameters	NN	0
of	of	IN	0
gonadotrope	gonadotrope	JJ	B-NP
function	function	NN	I-NP
(	(	-LRB-	0
p	p	CD	0
>	>	CD	0
0.05	0.05	CD	0
)	)	-RRB-	0
.	.	.	0
Discussion	Discussion	NN	0
The	The	DT	0
quantity	quantity	NN	0
of	of	IN	0
LH	LH	NNP	B-NP
secreted	secreted	NN	I-NP
by	by	IN	0
the	the	DT	0
anterior	anterior	JJ	0
pituitary	pituitary	JJ	B-NP
gland	gland	NN	I-NP
is	is	VBZ	0
the	the	DT	0
outcome	outcome	NN	0
of	of	IN	0
an	an	DT	0
interaction	interaction	NN	0
between	between	IN	0
the	the	DT	0
amount	amount	NN	0
of	of	IN	0
hypothalamic	hypothalamic	JJ	B-NP
GnRH	GnRH	JJ	I-NP
secretion	secretion	NN	I-NP
and	and	CC	0
the	the	DT	0
level	level	NN	0
of	of	IN	0
gonadotrope	gonadotrope	JJ	B-NP
responsiveness	responsiveness	NN	I-NP
to	to	TO	0
GnRH	GnRH	NNP	B-NP
[	[	-LRB-	0
7	7	CD	0
]	]	-RRB-	0
.	.	.	0
Quantitatively	Quantitatively	NNP	0
,	,	,	0
gonadotrope	gonadotrope	JJ	B-NP
responsiveness	responsiveness	NN	I-NP
is	is	VBZ	0
more	more	RBR	0
important	important	JJ	0
than	than	IN	0
the	the	DT	0
level	level	NN	0
of	of	IN	0
GnRH	GnRH	JJ	B-NP
secretion	secretion	NN	I-NP
;	;	:	0
for	for	IN	0
example	example	NN	0
,	,	,	0
during	during	IN	0
the	the	DT	0
lh	lh	NN	B-NP
secretion	secretion	NN	I-NP
estrogen-stimulated	estrogen-stimulated	JJ	I-NP
preovulatory	preovulatory	JJ	I-NP
surge	surge	NN	I-NP
in	in	IN	0
the	the	DT	0
rat	rat	NN	0
there	there	EX	0
is	is	VBZ	0
a	a	DT	0
5-fold	5-fold	JJ	0
increase	increase	NN	0
in	in	IN	0
GnRH	GnRH	JJ	B-NP
secretion	secretion	NN	I-NP
but	but	CC	0
a	a	DT	0
50-fold	50-fold	JJ	0
increase	increase	NN	0
in	in	IN	0
LH	LH	NNP	B-NP
secretion	secretion	NN	I-NP
[	[	-LRB-	0
7	7	CD	0
]	]	-RRB-	0
.	.	.	0
Moreover	Moreover	RB	0
,	,	,	0
a	a	DT	0
quantity	quantity	NN	0
of	of	IN	0
GnRH	GnRH	NN	B-NP
that	that	WDT	0
will	will	MD	0
evoke	evoke	VB	0
a	a	DT	0
normal	normal	JJ	B-NP
preovulatory	preovulatory	JJ	I-NP
LH	LH	NNP	I-NP
surge	surge	NN	I-NP
during	during	IN	0
the	the	DT	0
period	period	NN	0
preceding	preceding	VBG	0
ovulation	ovulation	NN	B-NP
will	will	MD	0
induce	induce	VB	0
only	only	RB	0
a	a	DT	0
small	small	JJ	0
increase	increase	NN	0
in	in	IN	0
LH	LH	NNP	B-NP
secretion	secretion	NN	I-NP
at	at	IN	0
other	other	JJ	0
stages	stages	NNS	0
of	of	IN	0
the	the	DT	0
estrous	estrous	JJ	B-NP
cycle	cycle	NN	I-NP
[	[	-LRB-	0
7	7	CD	0
]	]	-RRB-	0
.	.	.	0
Similarly	Similarly	RB	0
,	,	,	0
termination	termination	NN	0
of	of	IN	0
the	the	DT	0
preovulatory	preovulatory	JJ	B-NP
LH	LH	NNP	I-NP
surge	surge	NN	I-NP
appears	appears	VBZ	0
to	to	TO	0
be	be	VB	0
due	due	JJ	0
to	to	TO	0
gonadotrope	gonadotrope	NN	B-NP
desensitization	desensitization	VB	I-NP
to	to	TO	0
GnRH	GnRH	JJ	B-NP
action	action	NN	I-NP
;	;	:	0
in	in	IN	0
the	the	DT	0
sheep	sheep	NN	0
,	,	,	0
a	a	DT	0
decrease	decrease	NN	0
in	in	IN	0
LH	LH	NNP	B-NP
secretion	secretion	NN	I-NP
precedes	precedes	VBZ	0
the	the	DT	0
decrease	decrease	NN	0
in	in	IN	0
GnRH	GnRH	JJ	B-NP
secretion	secretion	NN	I-NP
[	[	-LRB-	0
41	41	CD	0
]	]	-RRB-	0
,	,	,	0
whereas	whereas	VBG	0
in	in	IN	0
the	the	DT	0
rat	rat	NN	0
,	,	,	0
although	although	IN	0
the	the	DT	0
decrease	decrease	NN	0
in	in	IN	0
GnRH	GnRH	JJ	0
and	and	CC	0
LH	LH	NNP	B-NP
secretion	secretion	NN	I-NP
are	are	VBP	0
co-incident	co-incident	JJ	B-NP
[	[	-LRB-	0
7	7	CD	0
]	]	-RRB-	0
,	,	,	0
there	there	EX	0
is	is	VBZ	0
evidence	evidence	NN	0
that	that	IN	0
the	the	DT	0
gonadotrope	gonadotrope	NN	B-NP
is	is	VBZ	0
already	already	RB	0
desensitized	desensitized	VBN	0
to	to	TO	0
GnRH	GnRH	NNP	B-NP
[	[	-LRB-	0
42	42	CD	0
43	43	CD	0
]	]	-RRB-	0
.	.	.	0
The	The	DT	0
mechanisms	mechanisms	NNS	0
that	that	WDT	0
alter	alter	VBP	0
gonadotrope	gonadotrope	JJ	B-NP
responsiveness	responsiveness	NN	I-NP
to	to	TO	0
GnRH	GnRH	NN	B-NP
are	are	VBP	0
unknown	unknown	JJ	0
but	but	CC	0
they	they	PRP	0
do	do	VBP	0
not	not	RB	0
appear	appear	VB	0
to	to	TO	0
be	be	VB	0
due	due	JJ	0
to	to	TO	0
GnRH	GnRH	JJ	B-NP
receptor	receptor	NN	I-NP
number	number	NN	0
or	or	CC	0
lh	lh	NN	B-NP
store	store	NN	I-NP
in	in	IN	0
the	the	DT	0
pituitary	pituitary	JJ	B-NP
gland	gland	NN	I-NP
[	[	-LRB-	0
5	5	CD	0
6	6	CD	0
7	7	CD	0
8	8	CD	0
]	]	-RRB-	0
.	.	.	0
However	However	RB	0
,	,	,	0
the	the	DT	0
lh	lh	NN	B-NP
fraction	fraction	NN	I-NP
that	that	WDT	0
is	is	VBZ	0
released	released	VBN	0
by	by	IN	0
a	a	DT	0
maximal	maximal	JJ	B-NP
dose	dose	NN	I-NP
of	of	IN	0
GnRH	GnRH	JJ	0
does	does	NNS	0
vary	vary	VBP	0
positively	positively	RB	0
with	with	IN	0
gonadotrope	gonadotrope	JJ	B-NP
responsiveness	responsiveness	NN	I-NP
[	[	-LRB-	0
7	7	CD	0
]	]	-RRB-	0
,	,	,	0
and	and	CC	0
elucidation	elucidation	NN	0
of	of	IN	0
the	the	DT	0
mechanisms	mechanisms	NNS	0
altering	altering	VBG	0
the	the	DT	0
releasable	releasable	JJ	B-NP
lh	lh	NN	I-NP
fraction	fraction	NN	I-NP
is	is	VBZ	0
likely	likely	JJ	0
to	to	TO	0
illuminate	illuminate	VB	0
mechanisms	mechanisms	NNS	0
of	of	IN	0
gonadotrope	gonadotrope	JJ	B-NP
responsiveness	responsiveness	NN	I-NP
to	to	TO	0
GnRH	GnRH	NNP	B-NP
[	[	-LRB-	0
44	44	CD	0
]	]	-RRB-	0
.	.	.	0
Two	Two	CD	0
molecular	molecular	JJ	B-NP
locus	locus	NN	I-NP
recently	recently	RB	0
have	have	VBP	0
been	been	VBN	0
implicated	implicated	VBN	0
as	as	IN	0
gnrh	gnrh	NN	B-NP
receptor	receptor	NN	I-NP
potential	potential	JJ	I-NP
modulator	modulator	NN	I-NP
signaling	signaling	NNS	0
:	:	:	0
one	one	PRP	0
is	is	VBZ	0
the	the	DT	0
receptor	receptor	NN	B-NP
itself	itself	PRP	0
[	[	-LRB-	0
23	23	CD	0
]	]	-RRB-	0
,	,	,	0
and	and	CC	0
the	the	DT	0
other	other	JJ	0
is	is	VBZ	0
the	the	DT	0
G	G	NNP	B-NP
protein	protein	NN	I-NP
that	that	IN	0
transduces	transduces	VBG	0
the	the	DT	0
signal	signal	NN	0
generated	generated	VBD	0
by	by	IN	0
binding	binding	VBG	0
of	of	IN	0
the	the	DT	0
receptor	receptor	NN	B-NP
to	to	TO	0
its	its	PRP$	0
agonist	agonist	NN	B-NP
[	[	-LRB-	0
9	9	CD	0
]	]	-RRB-	0
.	.	.	0
With	With	IN	0
respect	respect	NN	0
to	to	TO	0
the	the	DT	0
former	former	JJ	0
locus	locus	NN	0
,	,	,	0
G	G	NNP	B-NP
protein	protein	NN	I-NP
coupled	coupled	FW	0
receptor	receptor	NN	B-NP
kinas	kinas	NNP	I-NP
(	(	-LRB-	0
GRKs	GRKs	NNP	B-NP
)	)	-RRB-	0
act	act	NN	0
in	in	IN	0
an	an	DT	0
agonist-specific	agonist-specific	JJ	B-NP
manner	manner	NN	I-NP
to	to	TO	0
phosphorylate	phosphorylate	VB	0
receptor	receptor	NN	B-NP
intracellular	intracellular	JJ	I-NP
region	region	NN	I-NP
thus	thus	RB	0
permitting	permitting	VBG	0
β	β	JJ	0
arrestin	arrestin	JJ	0
binding	binding	NN	0
that	that	IN	0
sterically	sterically	JJ	0
inhibits	inhibits	JJ	0
G	G	NNP	B-NP
protein	protein	NN	I-NP
association	association	NN	I-NP
with	with	IN	0
the	the	DT	0
receptor	receptor	NN	B-NP
[	[	-LRB-	0
1	1	CD	0
45	45	CD	0
]	]	-RRB-	0
.	.	.	0
We	We	PRP	0
have	have	VBP	0
reported	reported	VBN	0
previously	previously	RB	0
that	that	IN	0
experimental	experimental	JJ	B-NP
expression	expression	NN	I-NP
of	of	IN	0
GRKs	GRKs	JJ	0
in	in	IN	0
gnrh	gnrh	NN	B-NP
receptor-expressing	receptor-expressing	JJ	I-NP
heterologous	heterologous	JJ	I-NP
cell	cell	NN	I-NP
(	(	-LRB-	0
COS-1	COS-1	NNP	B-NP
)	)	-RRB-	0
suppressed	suppressed	VBD	B-NP
GnRH-stimulated	GnRH-stimulated	NNP	I-NP
IP	IP	NNP	I-NP
3	3	CD	0
production	production	NN	0
,	,	,	0
and	and	CC	0
that	that	DT	0
grk2	grk2	NN	B-NP
co-expression	co-expression	JJ	I-NP
and	and	CC	0
β-arrestin	β-arrestin	JJ	B-NP
2	2	CD	0
suppressed	suppressed	CD	0
GnRH	GnRH	JJ	B-NP
receptor	receptor	NN	I-NP
signaling	signaling	VBG	0
more	more	JJR	0
than	than	IN	0
that	that	DT	0
of	of	IN	0
either	either	DT	0
alone	alone	RB	0
[	[	-LRB-	0
23	23	CD	0
]	]	-RRB-	0
.	.	.	0
Stronger	Stronger	JJR	B-NP
evidence	evidence	NN	I-NP
that	that	IN	0
the	the	DT	0
GRK	GRK	NN	B-NP
/	/	NN	I-NP
β	β	NN	I-NP
arrestin	arrestin	NN	I-NP
paradigm	paradigm	NN	I-NP
may	may	MD	0
play	play	VB	0
a	a	DT	0
role	role	NN	0
in	in	IN	0
regulating	regulating	VBG	0
GnRH	GnRH	JJ	B-NP
receptor	receptor	NN	I-NP
signaling	signaling	NN	I-NP
is	is	VBZ	0
our	our	PRP$	0
recent	recent	JJ	0
finding	finding	NN	0
that	that	IN	0
grk2	grk2	NN	B-NP
adenovirus-mediated	adenovirus-mediated	JJ	I-NP
gene	gene	NN	I-NP
transfer	transfer	NN	I-NP
into	into	IN	0
suppressed	suppressed	VBN	B-NP
gnrh-stimulated	gnrh-stimulated	NN	I-NP
lh	lh	NN	I-NP
secretion	secretion	NN	I-NP
normal	normal	JJ	I-NP
pituitary	pituitary	JJ	I-NP
gonadotrope	gonadotrope	NN	I-NP
and	and	CC	0
IP	IP	NNP	B-NP
3	3	CD	0
production	production	NN	0
[	[	-LRB-	0
31	31	CD	0
]	]	-RRB-	0
.	.	.	0
However	However	RB	0
,	,	,	0
no	no	DT	0
evidence	evidence	NN	0
has	has	VBZ	0
been	been	VBN	0
presented	presented	VBN	0
for	for	IN	0
a	a	DT	0
direct	direct	JJ	0
interaction	interaction	NN	0
between	between	IN	0
β-arrestin	β-arrestin	JJ	B-NP
and	and	CC	0
the	the	DT	0
GnRH	GnRH	JJ	B-NP
receptor	receptor	NN	I-NP
.	.	.	0
With	With	IN	0
respect	respect	NN	0
to	to	TO	0
the	the	DT	0
G	G	NNP	B-NP
protein	protein	NN	I-NP
as	as	IN	0
a	a	DT	0
locus	locus	NN	0
for	for	IN	0
gnrh	gnrh	NN	B-NP
receptor	receptor	NN	I-NP
signaling	signaling	NN	I-NP
modulation	modulation	NN	I-NP
,	,	,	0
we	we	PRP	0
reported	reported	VBD	0
earlier	earlier	RBR	0
that	that	IN	0
rgs3	rgs3	NN	B-NP
experimental	experimental	JJ	I-NP
expression	expression	NN	I-NP
but	but	CC	0
not	not	RB	0
RGS1	RGS1	CD	B-NP
,	,	,	0
2	2	CD	0
,	,	,	0
or	or	CC	0
4	4	CD	0
in	in	IN	0
expressing	expressing	VBG	B-NP
cos-1	cos-1	NN	I-NP
cell	cell	NN	I-NP
gnrh	gnrh	NN	I-NP
receptor	receptor	NN	I-NP
suppressed	suppressed	VBD	B-NP
GnRH-stimulated	GnRH-stimulated	NNP	I-NP
IP	IP	NNP	I-NP
3	3	CD	0
production	production	NN	0
[	[	-LRB-	0
9	9	CD	0
]	]	-RRB-	0
.	.	.	0
In	In	IN	0
the	the	DT	0
current	current	JJ	0
report	report	NN	0
,	,	,	0
we	we	PRP	0
present	present	JJ	0
evidence	evidence	NN	0
strengthening	strengthening	VBG	0
the	the	DT	0
hypothesis	hypothesis	NN	0
of	of	IN	0
a	a	DT	0
rgs3	rgs3	NN	B-NP
regulatory	regulatory	JJ	I-NP
role	role	NN	I-NP
in	in	IN	0
GnRH	GnRH	JJ	B-NP
receptor	receptor	NN	I-NP
signaling	signaling	NNS	0
:	:	:	0
rgs3	rgs3	NN	B-NP
adenovirus-mediated	adenovirus-mediated	JJ	I-NP
expression	expression	NN	I-NP
in	in	IN	0
normal	normal	JJ	B-NP
pituitary	pituitary	JJ	I-NP
gonadotrope	gonadotrope	NN	I-NP
profoundly	profoundly	FW	0
inhibited	inhibited	VBN	B-NP
GnRH-stimulated	GnRH-stimulated	NN	I-NP
LH	LH	NN	I-NP
secretion	secretion	NN	I-NP
and	and	CC	0
3H-inositol	3H-inositol	CD	0
phosphate	phosphate	JJ	0
accumulation	accumulation	NN	0
.	.	.	0
Arguing	Arguing	VBG	0
for	for	IN	0
the	the	DT	0
specificity	specificity	NN	0
of	of	IN	0
this	this	DT	0
effect	effect	NN	0
is	is	VBZ	0
the	the	DT	0
stimulation	stimulation	NN	0
of	of	IN	0
LH	LH	NNP	B-NP
secretion	secretion	NN	I-NP
by	by	IN	0
a	a	DT	0
calcium	calcium	JJ	B-NP
ionophore	ionophore	NN	I-NP
and	and	CC	0
the	the	DT	0
failure	failure	NN	0
of	of	IN	0
lh	lh	NN	B-NP
store	store	NN	I-NP
and	and	CC	0
GnRH-receptor	GnRH-receptor	JJ	B-NP
binding	binding	NN	I-NP
to	to	TO	0
be	be	VB	0
affected	affected	VBN	0
by	by	IN	0
RGS3	RGS3	CD	B-NP
.	.	.	0
Moreover	Moreover	RB	0
,	,	,	0
our	our	PRP$	0
finding	finding	NN	0
that	that	IN	0
GnRH-stimulated	GnRH-stimulated	NNP	B-NP
IP	IP	NNP	I-NP
3	3	CD	0
production	production	NN	0
was	was	VBD	0
inhibited	inhibited	RB	0
supports	supports	VBZ	0
the	the	DT	0
locus	locus	NN	0
of	of	IN	0
the	the	DT	0
RGS3	RGS3	JJ	B-NP
effect	effect	NN	I-NP
as	as	IN	0
residing	residing	NN	0
at	at	IN	0
phospholipase	phospholipase	JJ	0
C	C	NNP	0
or	or	CC	0
earlier	earlier	RBR	0
in	in	IN	0
the	the	DT	0
transduction	transduction	JJ	B-NP
pathway	pathway	NN	I-NP
,	,	,	0
most	most	RBS	0
likely	likely	JJ	0
at	at	IN	0
the	the	DT	0
Gα	Gα	JJ	B-NP
protein	protein	NN	I-NP
because	because	IN	0
of	of	IN	0
our	our	PRP$	0
studies	studies	NNS	0
both	both	CC	0
earlier	earlier	RBR	0
[	[	-LRB-	0
9	9	CD	0
]	]	-RRB-	0
and	and	CC	0
here	here	RB	0
showing	showing	VBG	0
that	that	IN	0
gqα	gqα	NN	B-NP
rgs3	rgs3	NN	I-NP
bind	bind	NN	I-NP
in	in	FW	0
vitro	vitro	NNP	B-NP
.	.	.	0
Finally	Finally	RB	0
,	,	,	0
the	the	DT	0
stronger	stronger	JJR	0
inhibitory	inhibitory	JJ	B-NP
effect	effect	NN	I-NP
of	of	IN	0
RGS3T	RGS3T	CD	0
than	than	IN	0
rg	rg	NN	B-NP
3	3	CD	0
on	on	IN	0
COS	COS	NNP	B-NP
cell	cell	NN	0
function	function	NN	0
was	was	VBD	0
presumed	presumed	VBN	0
to	to	TO	0
be	be	VB	0
true	true	JJ	0
also	also	RB	0
for	for	IN	0
gonadotrope	gonadotrope	JJ	B-NP
function	function	NN	I-NP
and	and	CC	0
therefore	therefore	RB	0
was	was	VBD	0
not	not	RB	0
tested	tested	VBN	0
here	here	RB	0
.	.	.	0
The	The	DT	0
rg	rg	NN	B-NP
determination	determination	NN	I-NP
specificity	specificity	NN	0
for	for	IN	0
receptor-g	receptor-g	NN	B-NP
protein	protein	NN	I-NP
pair	pair	NN	I-NP
are	are	VBP	0
currently	currently	RB	0
unknown	unknown	JJ	0
;	;	:	0
i.e.	i.e.	FW	0
,	,	,	0
we	we	PRP	0
and	and	CC	0
others	others	NNS	0
have	have	VBP	0
found	found	VBN	0
that	that	IN	0
several	several	JJ	0
RGSs	RGSs	JJ	0
interact	interact	NN	0
with	with	IN	0
Gqα	Gqα	NNP	B-NP
but	but	CC	0
only	only	RB	0
one	one	CD	0
,	,	,	0
RGS3	RGS3	NNP	B-NP
,	,	,	0
has	has	VBZ	0
potent	potent	JJ	0
inhibitory	inhibitory	JJ	B-NP
activity	activity	NN	I-NP
on	on	IN	0
GnRH	GnRH	JJ	B-NP
receptor	receptor	NN	I-NP
signaling	signaling	NN	I-NP
.	.	.	0
For	For	IN	0
instance	instance	NN	0
,	,	,	0
RGS4	RGS4	NNP	B-NP
and	and	CC	0
RGS-GAIP	RGS-GAIP	NNP	B-NP
[	[	-LRB-	0
11	11	CD	0
]	]	-RRB-	0
,	,	,	0
RGS3	RGS3	NNP	B-NP
[	[	-LRB-	0
9	9	CD	0
]	]	-RRB-	0
,	,	,	0
RGS2	RGS2	NNP	B-NP
[	[	-LRB-	0
46	46	CD	0
]	]	-RRB-	0
,	,	,	0
and	and	CC	0
RGS7	RGS7	NNP	B-NP
(	(	-LRB-	0
our	our	PRP$	0
unpublished	unpublished	JJ	0
findings	findings	NNS	0
)	)	-RRB-	0
all	all	DT	0
bind	bind	NN	B-NP
Gqα	Gqα	NNP	I-NP
,	,	,	0
the	the	DT	0
established	established	JJ	0
G	G	NNP	B-NP
protein	protein	NN	I-NP
that	that	IN	0
transduces	transduces	JJ	B-NP
GnRH	GnRH	JJ	I-NP
receptor	receptor	NN	I-NP
signaling	signaling	NNS	0
[	[	-LRB-	0
38	38	CD	0
]	]	-RRB-	0
.	.	.	0
Nevertheless	Nevertheless	RB	0
,	,	,	0
RGS2	RGS2	NNP	B-NP
and	and	CC	0
4	4	CD	0
[	[	-LRB-	0
9	9	CD	0
]	]	-RRB-	0
,	,	,	0
and	and	CC	0
RGS-GAIP	RGS-GAIP	JJ	B-NP
and	and	CC	0
RGS7	RGS7	NNP	B-NP
(	(	-LRB-	0
our	our	PRP$	0
unpublished	unpublished	JJ	0
data	data	NNS	0
)	)	-RRB-	0
are	are	VBP	0
weak	weak	JJ	0
or	or	CC	0
null	null	JJ	0
inhibitors	inhibitors	NN	0
of	of	IN	0
GnRH	GnRH	JJ	B-NP
receptor	receptor	NN	I-NP
signaling	signaling	NN	I-NP
.	.	.	0
A	A	DT	0
recent	recent	JJ	0
report	report	NN	0
seems	seems	VBZ	0
to	to	TO	0
have	have	VB	0
clarified	clarified	VBN	0
this	this	DT	0
issue	issue	NN	0
:	:	:	0
RGS4	RGS4	NNP	B-NP
must	must	MD	0
bind	bind	VB	0
not	not	RB	0
only	only	RB	0
Gqα	Gqα	NNP	B-NP
but	but	CC	0
also	also	RB	0
selected	selected	VBN	B-NP
gq-coupled	gq-coupled	NN	I-NP
receptor	receptor	NN	I-NP
before	before	IN	0
it	it	PRP	0
can	can	MD	0
inhibit	inhibit	VB	0
receptor	receptor	JJ	0
signaling	signaling	NNS	0
[	[	-LRB-	0
47	47	CD	0
48	48	CD	0
]	]	-RRB-	0
.	.	.	0
Based	Based	VBN	0
on	on	IN	0
this	this	DT	0
finding	finding	NN	0
,	,	,	0
we	we	PRP	0
propose	propose	VBP	0
that	that	IN	0
RGS3	RGS3	NNP	0
's	's	POS	0
binding	binding	JJ	0
to	to	TO	0
the	the	DT	0
GnRH	GnRH	JJ	B-NP
receptor	receptor	NN	I-NP
as	as	IN	0
well	well	RB	0
as	as	RB	0
to	to	TO	0
gqα	gqα	NN	B-NP
account	account	NN	I-NP
for	for	IN	0
its	its	PRP$	0
specific	specific	JJ	0
inhibiting	inhibiting	NN	0
of	of	IN	0
GnRH	GnRH	JJ	B-NP
receptor	receptor	NN	I-NP
signaling	signaling	NN	I-NP
.	.	.	0
Conclusions	Conclusions	NNS	0
The	The	DT	0
results	results	NNS	0
of	of	IN	0
the	the	DT	0
current	current	JJ	0
investigation	investigation	NN	B-NP
as	as	IN	0
well	well	RB	0
as	as	IN	0
those	those	DT	0
presented	presented	VBN	0
earlier	earlier	RBR	0
[	[	-LRB-	0
31	31	CD	0
]	]	-RRB-	0
nominate	nominate	VB	0
two	two	CD	0
molecular	molecular	JJ	B-NP
mechanism	mechanism	NN	I-NP
as	as	IN	0
playing	playing	VBG	0
roles	roles	NNS	0
in	in	IN	0
setting	setting	VBG	0
the	the	DT	0
gnrh	gnrh	NN	B-NP
receptor	receptor	NN	I-NP
responsiveness	responsiveness	JJ	I-NP
level	level	NN	I-NP
signaling	signaling	NNS	0
;	;	:	0
i.e.	i.e.	FW	0
,	,	,	0
the	the	DT	0
rgs3	rgs3	NN	B-NP
system	system	NN	I-NP
act	act	NN	I-NP
at	at	IN	0
the	the	DT	0
G	G	NNP	B-NP
protein	protein	NN	I-NP
transducing	transducing	NN	I-NP
step	step	NN	I-NP
and	and	CC	0
the	the	DT	0
grk/β	grk/β	NN	B-NP
arrestin	arrestin	JJ	I-NP
system	system	NN	I-NP
act	act	NN	I-NP
at	at	IN	0
the	the	DT	0
level	level	NN	0
of	of	IN	0
the	the	DT	0
receptor	receptor	NN	B-NP
.	.	.	0
Future	Future	JJ	0
studies	studies	NNS	0
must	must	MD	0
address	address	VB	0
whether	whether	IN	0
both	both	DT	0
,	,	,	0
neither	neither	RB	0
,	,	,	0
or	or	CC	0
only	only	RB	0
one	one	CD	0
of	of	IN	0
these	these	DT	0
mechanisms	mechanisms	NNS	0
are	are	VBP	0
physiologically	physiologically	JJ	B-NP
relevant	relevant	JJ	I-NP
.	.	.	0
Materials	Materials	NNS	0
and	and	CC	0
Methods	Methods	NNP	0
cos-1	cos-1	NN	B-NP
cell	cell	NN	I-NP
cdna	cdna	NN	I-NP
transfection	transfection	NN	I-NP
and	and	CC	0
measurement	measurement	NN	0
of	of	IN	0
IP	IP	NNP	0
3production	3production	NNP	0
cDNA	cDNA	NNP	0
representing	representing	VBG	0
the	the	DT	0
rat	rat	JJ	0
GnRH	GnRH	JJ	B-NP
receptor	receptor	NN	I-NP
was	was	VBD	0
cloned	cloned	VBN	0
into	into	IN	0
pcDNA3	pcDNA3	NNP	B-NP
as	as	RB	0
described	described	VBN	0
and	and	CC	0
validated	validated	VBP	0
previously	previously	RB	0
[	[	-LRB-	0
22	22	CD	0
23	23	CD	0
]	]	-RRB-	0
.	.	.	0
representing	representing	VBG	B-NP
rgs3	rgs3	NN	I-NP
cdna	cdna	NN	I-NP
and	and	CC	0
RGS3T	RGS3T	NNP	0
(	(	-LRB-	0
RGS3	RGS3	NN	B-NP
amino	amino	FW	0
acids	acids	FW	0
314-519	314-519	FW	0
)	)	-RRB-	0
were	were	VBD	0
cloned	cloned	VBN	0
into	into	IN	0
the	the	DT	0
eukaryotic	eukaryotic	JJ	B-NP
expression	expression	NN	I-NP
vector	vector	NN	I-NP
,	,	,	0
rcCMV	rcCMV	NNP	B-NP
,	,	,	0
as	as	RB	0
described	described	VBN	0
[	[	-LRB-	0
24	24	CD	0
]	]	-RRB-	0
.	.	.	0
cos-1	cos-1	NN	B-NP
cell	cell	NN	I-NP
cultured	cultured	VBP	0
as	as	RB	0
detailed	detailed	VBN	0
before	before	IN	0
[	[	-LRB-	0
23	23	CD	0
]	]	-RRB-	0
were	were	VBD	0
co-transfected	co-transfected	JJ	B-NP
with	with	IN	0
GnRH	GnRH	JJ	B-NP
receptor	receptor	NN	I-NP
cDNA	cDNA	NN	I-NP
and	and	CC	0
RGS3	RGS3	NNP	B-NP
or	or	CC	0
RGS3T	RGS3T	CD	0
cDNA	cDNA	JJ	0
using	using	VBG	0
Lipofectamine	Lipofectamine	NNP	B-NP
(	(	-LRB-	0
Life	Life	NNP	0
Technologies	Technologies	NNPS	0
,	,	,	0
Gaithersburg	Gaithersburg	NNP	0
,	,	,	0
MD	MD	NNP	0
)	)	-RRB-	0
[	[	-LRB-	0
23	23	CD	0
]	]	-RRB-	0
,	,	,	0
and	and	CC	0
72	72	CD	0
h	h	NNS	0
later	later	RB	0
,	,	,	0
treated	treated	VBN	0
with	with	IN	0
10	10	CD	0
-7M	-7M	CD	0
GnRH-A	GnRH-A	NN	0
for	for	IN	0
0	0	CD	0
,	,	,	0
10	10	CD	0
,	,	,	0
20	20	CD	0
,	,	,	0
or	or	CC	0
30	30	CD	0
sec	sec	NN	0
before	before	IN	0
being	being	VBG	0
collected	collected	VBN	0
for	for	IN	0
IP	IP	NNP	B-NP
3	3	CD	0
measurement	measurement	NN	B-NP
[	[	-LRB-	0
22	22	CD	0
23	23	CD	0
]	]	-RRB-	0
.	.	.	0
IP	IP	NNP	0
3	3	CD	0
measurements	measurements	NNS	0
were	were	VBD	0
performed	performed	VBN	0
on	on	IN	0
COS-1	COS-1	CD	0
cell	cell	NN	0
cytosolic	cytosolic	NNS	0
preparations	preparations	VBP	0
using	using	VBG	0
a	a	DT	0
radioreceptor	radioreceptor	JJ	0
assay	assay	NN	0
in	in	IN	0
which	which	WDT	0
IP	IP	NNP	0
3	3	CD	0
and	and	CC	0
3H-IP	3H-IP	CD	0
3	3	CD	0
compete	compete	NN	0
for	for	IN	0
binding	binding	VBG	0
to	to	TO	0
IP	IP	NNP	0
3	3	CD	0
receptors	receptors	NNS	0
prepared	prepared	VBN	0
from	from	IN	0
calf	calf	FW	0
cerebellum	cerebellum	FW	0
membranes	membranes	FW	0
[	[	-LRB-	0
22	22	CD	0
23	23	CD	0
]	]	-RRB-	0
.	.	.	0
gα-protein	gα-protein	NN	B-NP
rgs3	rgs3	NN	I-NP
binding	binding	NN	I-NP
in	in	IN	0
vitro	vitro	CD	B-NP
RGS3	RGS3	CD	I-NP
protein	protein	NN	I-NP
fused	fused	NN	I-NP
to	to	TO	0
glutathione-S-transferase	glutathione-S-transferase	NNP	B-NP
(	(	-LRB-	0
RSG3-GST	RSG3-GST	NNP	B-NP
fusion	fusion	NN	I-NP
protein	protein	NN	I-NP
)	)	-RRB-	0
was	was	VBD	0
produced	produced	VBN	0
in	in	IN	0
the	the	DT	0
pharmacia	pharmacia	NN	B-NP
pgex-5x-1	pgex-5x-1	NN	I-NP
system	system	NN	I-NP
as	as	RB	0
detailed	detailed	VBN	0
previously	previously	RB	0
[	[	-LRB-	0
9	9	CD	0
]	]	-RRB-	0
.	.	.	0
35S-Met	35S-Met	FW	0
labeled	labeled	VBN	B-NP
gα-protein	gα-protein	NN	I-NP
were	were	VBD	0
prepared	prepared	VBN	0
in	in	IN	0
vitro	vitro	NN	B-NP
using	using	VBG	0
a	a	DT	0
transcription	transcription	NN	B-NP
/	/	NN	I-NP
translation	translation	NN	I-NP
protocol	protocol	NN	I-NP
[	[	-LRB-	0
9	9	CD	0
]	]	-RRB-	0
.	.	.	0
cDNAs	cDNAs	JJ	0
for	for	IN	0
Gqα	Gqα	NNP	B-NP
[	[	-LRB-	0
25	25	CD	0
]	]	-RRB-	0
and	and	CC	0
Gzα	Gzα	NNP	B-NP
[	[	-LRB-	0
26	26	CD	0
]	]	-RRB-	0
were	were	VBD	0
obtained	obtained	VBN	0
from	from	IN	0
M.	M.	NNP	0
I.	I.	NNP	0
Simon	Simon	NNP	0
;	;	:	0
for	for	IN	0
Gsα	Gsα	NNP	B-NP
(	(	-LRB-	0
ref	ref	NN	B-NP
.	.	.	0
No.	No.	NNP	0
63315	63315	CD	0
)	)	-RRB-	0
and	and	CC	0
Gi2α	Gi2α	NNP	B-NP
(	(	-LRB-	0
ref	ref	NN	B-NP
.	.	.	0
No.	No.	NNP	0
63311	63311	CD	0
)	)	-RRB-	0
were	were	VBD	0
obtained	obtained	VBN	0
from	from	IN	0
the	the	DT	0
American	American	NNP	B-NP
Type	Type	NNP	I-NP
Culture	Culture	NNP	I-NP
Collection	Collection	NNP	I-NP
(	(	-LRB-	0
ATCC	ATCC	NNP	B-NP
)	)	-RRB-	0
;	;	:	0
for	for	IN	0
Gαo	Gαo	NNP	B-NP
[	[	-LRB-	0
27	27	CD	0
]	]	-RRB-	0
was	was	VBD	0
obtained	obtained	VBN	0
from	from	IN	0
Eva	Eva	NNP	0
G.	G.	NNP	0
Neer	Neer	NNP	0
;	;	:	0
for	for	IN	0
Gi1α	Gi1α	NNP	B-NP
,	,	,	0
[	[	-LRB-	0
28	28	CD	0
]	]	-RRB-	0
from	from	IN	0
G.	G.	NNP	B-NP
R.	R.	NNP	I-NP
Post	Post	NNP	I-NP
;	;	:	0
and	and	CC	0
,	,	,	0
for	for	IN	0
Gi3α	Gi3α	NNP	B-NP
[	[	-LRB-	0
29	29	CD	0
]	]	-RRB-	0
from	from	IN	0
M.	M.	NNP	0
G.	G.	NNP	0
Farquhar	Farquhar	NNP	0
.	.	.	0
binding	binding	JJ	B-NP
study	study	NN	I-NP
of	of	IN	0
recombinant	recombinant	JJ	0
RGS3-GST	RGS3-GST	CD	B-NP
fusion	fusion	NN	I-NP
protein	protein	NN	I-NP
to	to	TO	0
35S-Met-Gα-proteins	35S-Met-Gα-proteins	NNP	0
were	were	VBD	0
performed	performed	VBN	0
as	as	IN	0
detailed	detailed	JJ	0
[	[	-LRB-	0
9	9	CD	0
]	]	-RRB-	0
.	.	.	0
glutathione-coupled	glutathione-coupled	NN	B-NP
bead	bead	NN	I-NP
were	were	VBD	0
used	used	VBN	0
to	to	TO	0
select	select	VB	0
35S-Gα	35S-Gα	CD	0
proteins	proteins	NNS	0
bound	bound	VBN	0
to	to	TO	0
RGS3-GST	RGS3-GST	CD	B-NP
,	,	,	0
and	and	CC	0
were	were	VBD	0
then	then	RB	0
eluted	eluted	VBN	0
for	for	IN	0
separation	separation	NN	0
by	by	IN	0
SDS	SDS	NNP	B-NP
/	/	NNP	I-NP
PAGE	PAGE	NNP	I-NP
[	[	-LRB-	0
9	9	CD	0
]	]	-RRB-	0
.	.	.	0
The	The	DT	0
amount	amount	NN	0
and	and	CC	0
molecular	molecular	JJ	B-NP
size	size	NN	I-NP
of	of	IN	0
35S-Gα	35S-Gα	CD	0
protein	protein	NN	0
were	were	VBD	0
determined	determined	VBN	0
using	using	VBG	0
a	a	DT	0
Phosphor	Phosphor	JJ	B-NP
imaging	imaging	NN	I-NP
device	device	NN	I-NP
(	(	-LRB-	0
molecular	molecular	JJ	B-NP
dynamic	dynamic	JJ	I-NP
)	)	-RRB-	0
.	.	.	0
Preparation	Preparation	NN	0
of	of	IN	0
Adeno-RGS3	Adeno-RGS3	NNP	0
Recombinant	Recombinant	NNP	0
adenovirus	adenovirus	VBZ	0
containing	containing	VBG	0
RGS3	RGS3	NNP	0
cDNA	cDNA	NNP	0
was	was	VBD	0
prepared	prepared	VBN	0
using	using	VBG	0
procedures	procedures	NNS	0
previously	previously	RB	0
described	described	VBN	0
in	in	IN	0
detail	detail	NN	0
by	by	IN	0
Becker	Becker	NNP	0
et	et	FW	0
al.	al.	FW	0
[	[	-LRB-	0
30	30	CD	0
]	]	-RRB-	0
and	and	CC	0
by	by	IN	0
us	us	PRP	0
[	[	-LRB-	0
31	31	CD	0
]	]	-RRB-	0
.	.	.	0
Human	Human	NNP	B-NP
RGS3	RGS3	NNP	I-NP
cDNA	cDNA	NNP	I-NP
[	[	-LRB-	0
24	24	CD	0
]	]	-RRB-	0
was	was	VBD	0
restricted	restricted	VBN	0
from	from	IN	0
the	the	DT	0
pRC	pRC	JJ	B-NP
/	/	NNP	I-NP
CMV	CMV	NNP	I-NP
vector	vector	NN	I-NP
with	with	IN	0
EcoRI	EcoRI	NNP	B-NP
,	,	,	0
and	and	CC	0
then	then	RB	0
subcloned	subcloned	VBN	0
into	into	IN	0
the	the	DT	0
corresponding	corresponding	JJ	0
site	site	NN	0
of	of	IN	0
the	the	DT	0
pACCMVpLpa	pACCMVpLpa	JJ	B-NP
plasmid	plasmid	NN	I-NP
.	.	.	0
The	The	DT	0
proper	proper	JJ	0
orientation	orientation	NN	0
of	of	IN	0
the	the	DT	0
RGS3	RGS3	NNP	B-NP
cDNA	cDNA	NNP	I-NP
was	was	VBD	0
confirmed	confirmed	VBN	0
by	by	IN	0
nucleotide	nucleotide	JJ	B-NP
sequencing	sequencing	NN	I-NP
.	.	.	0
The	The	DT	0
procedure	procedure	NN	0
for	for	IN	0
adenovirus	adenovirus	NN	B-NP
preparation	preparation	NN	I-NP
was	was	VBD	0
co-transfection	co-transfection	JJ	B-NP
of	of	IN	0
a	a	DT	0
human	human	JJ	0
embryonic	embryonic	JJ	B-NP
kidney	kidney	NN	I-NP
cell	cell	NN	I-NP
line	line	NN	I-NP
(	(	-LRB-	0
HEK	HEK	NNP	0
293	293	CD	0
)	)	-RRB-	0
with	with	IN	0
the	the	DT	0
pACCMVpLpa	pACCMVpLpa	JJ	B-NP
plasmid	plasmid	NN	I-NP
and	and	CC	0
another	another	DT	0
plasmid	plasmid	NN	B-NP
(	(	-LRB-	0
pJM17	pJM17	NNP	B-NP
)	)	-RRB-	0
containing	containing	VBG	0
most	most	JJS	0
of	of	IN	0
the	the	DT	0
viral	viral	JJ	B-NP
genoma	genoma	NN	I-NP
[	[	-LRB-	0
30	30	CD	0
]	]	-RRB-	0
.	.	.	0
A	A	DT	0
relatively	relatively	RB	0
rare	rare	JJ	0
recombination	recombination	NN	B-NP
of	of	IN	0
the	the	DT	0
two	two	CD	0
plasmid	plasmid	NN	B-NP
occurs	occurs	VBZ	0
in	in	IN	0
the	the	DT	0
HEK	HEK	NNP	B-NP
293	293	CD	0
cells	cells	NNS	0
that	that	WDT	0
reconstitutes	reconstitutes	VBZ	0
the	the	DT	0
adenoviral	adenoviral	JJ	B-NP
genome	genome	NN	I-NP
.	.	.	0
The	The	DT	0
reconstituting	reconstituting	VBD	B-NP
adeno-rgs3	adeno-rgs3	NN	I-NP
recombination	recombination	JJ	I-NP
event	event	NN	I-NP
was	was	VBD	0
confirmed	confirmed	VBN	0
using	using	VBG	0
PCR	PCR	NNP	B-NP
analysis	analysis	NN	I-NP
to	to	TO	0
detect	detect	VB	0
the	the	DT	0
presence	presence	NN	0
of	of	IN	0
RGS3	RGS3	NNP	B-NP
cDNA	cDNA	NNP	I-NP
.	.	.	0
Next	Next	JJ	B-NP
,	,	,	0
adeno-RGS3	adeno-RGS3	NNP	B-NP
was	was	VBD	0
isolated	isolated	VBN	0
by	by	IN	0
clonal	clonal	JJ	B-NP
selection	selection	NN	I-NP
in	in	IN	0
HEK	HEK	NNP	B-NP
293	293	CD	0
cells	cells	NNS	0
followed	followed	VBN	0
by	by	IN	0
a	a	DT	0
second	second	JJ	0
PCR	PCR	NN	B-NP
to	to	TO	0
confirm	confirm	VB	0
the	the	DT	0
presence	presence	NN	0
of	of	IN	0
RGS3	RGS3	NNP	B-NP
cDNA	cDNA	NNP	I-NP
.	.	.	0
Finally	Finally	RB	0
,	,	,	0
large-scale	large-scale	JJ	0
amplification	amplification	NN	B-NP
and	and	CC	0
adeno-rgs3	adeno-rgs3	NN	B-NP
titering	titering	NN	I-NP
was	was	VBD	0
performed	performed	VBN	0
in	in	IN	0
HEK	HEK	NNP	B-NP
293	293	CD	0
cells	cells	NNS	0
.	.	.	0
This	This	DT	0
virus	virus	NN	0
preparation	preparation	NN	0
was	was	VBD	0
used	used	VBN	0
for	for	IN	0
infection	infection	NN	0
of	of	IN	0
rat	rat	JJ	0
pituitary	pituitary	JJ	0
cells	cells	NNS	0
[	[	-LRB-	0
31	31	CD	0
]	]	-RRB-	0
.	.	.	0
Culture	Culture	NN	0
and	and	CC	0
infection	infection	NN	B-NP
of	of	IN	0
rat	rat	FW	0
pituitary	pituitary	FW	0
cells	cells	FW	0
Anterior	Anterior	FW	0
pituitary	pituitary	FW	0
glands	glands	NN	0
were	were	VBD	0
obtained	obtained	VBN	0
from	from	IN	0
female	female	JJ	0
Charles	Charles	NNP	0
River	River	NNP	0
CD	CD	NNP	0
rats	rats	NNS	0
that	that	WDT	0
were	were	VBD	0
maintained	maintained	VBN	0
in	in	IN	0
accordance	accordance	NN	0
with	with	IN	0
the	the	DT	0
NIH	NIH	NNP	B-NP
Guide	Guide	NNP	0
for	for	IN	0
the	the	DT	0
Care	Care	NNP	0
and	and	CC	0
Use	Use	NN	0
of	of	IN	0
Laboratory	Laboratory	NNP	0
Animals	Animals	NNPS	0
using	using	VBG	0
an	an	DT	0
experimental	experimental	JJ	B-NP
protocol	protocol	NN	I-NP
that	that	WDT	0
had	had	VBD	0
been	been	VBN	0
approved	approved	VBN	0
by	by	IN	0
the	the	DT	0
Institutional	Institutional	NNP	B-NP
Animal	Animal	NNP	I-NP
Care	Care	NNP	I-NP
and	and	CC	0
Use	Use	NNP	B-NP
Committee	Committee	NNP	I-NP
.	.	.	0
The	The	DT	0
pituitaries	pituitaries	NN	0
were	were	VBD	0
dispersed	dispersed	VBN	0
with	with	IN	0
trypsin	trypsin	VBG	0
as	as	RB	0
described	described	VBN	0
before	before	IN	0
[	[	-LRB-	0
32	32	CD	0
]	]	-RRB-	0
.	.	.	0
The	The	DT	0
mono-dispersed	mono-dispersed	JJ	0
cells	cells	NNS	0
were	were	VBD	0
plated	plated	VBN	0
into	into	IN	0
poly-L-lysine	poly-L-lysine	JJ	B-NP
coated	coated	JJ	0
60	60	CD	0
mm	mm	CD	0
plastic	plastic	JJ	B-NP
petri	petri	NNP	I-NP
dish	dish	NN	I-NP
in	in	IN	0
DMEM	DMEM	NNP	B-NP
/	/	CD	0
10	10	CD	0
%	%	NN	0
gelding	gelding	NN	B-NP
horse	horse	NN	I-NP
serum	serum	VBZ	I-NP
containing	containing	VBG	0
10	10	CD	0
-9M	-9M	CD	0
estradiol	estradiol	NN	0
to	to	TO	0
optimize	optimize	VB	0
the	the	DT	0
gonadotrope	gonadotrope	NN	B-NP
gnrh-responsiveness	gnrh-responsiveness	NN	I-NP
[	[	-LRB-	0
33	33	CD	0
]	]	-RRB-	0
,	,	,	0
and	and	CC	0
incubated	incubated	JJ	0
overnight	overnight	JJ	0
at	at	IN	0
37°C	37°C	CD	0
in	in	IN	0
8	8	CD	0
%	%	NN	0
CO	CO	NNP	0
2	2	CD	0
-92	-92	CD	0
%	%	NN	0
air	air	NN	0
.	.	.	0
Pituitary	Pituitary	JJ	0
cells	cells	NNS	0
were	were	VBD	0
infected	infected	VBN	0
using	using	VBG	0
a	a	DT	0
volume	volume	NN	0
of	of	IN	0
adeno-RGS3	adeno-RGS3	NNP	0
or	or	CC	0
adeno-β	adeno-β	JJ	0
galactosidase	galactosidase	JJ	0
necessary	necessary	JJ	0
to	to	TO	0
achieve	achieve	VB	0
the	the	DT	0
chosen	chosen	JJ	0
multiplicity	multiplicity	NN	0
of	of	IN	0
infection	infection	NN	0
(	(	-LRB-	0
M.O.I.	M.O.I.	NNP	0
)	)	-RRB-	0
diluted	diluted	VBN	0
to	to	TO	0
0.3	0.3	CD	0
ml	ml	NNS	0
;	;	:	0
this	this	DT	0
was	was	VBD	0
further	further	RB	0
diluted	diluted	VBN	0
with	with	IN	0
1.2	1.2	CD	0
ml	ml	NN	0
of	of	IN	0
TS	TS	NNP	0
buffer	buffer	NN	0
(	(	-LRB-	0
8.0	8.0	FW	0
gm	gm	FW	0
/	/	FW	0
L	L	NNP	0
NaCI	NaCI	NNP	0
,	,	,	0
380	380	CD	0
mg	mg	CD	0
/	/	CD	0
L	L	NNP	0
KCl	KCl	NNP	0
,	,	,	0
100	100	CD	0
mg	mg	CD	0
/	/	CD	0
L	L	NNP	0
Na	Na	NNP	0
2	2	CD	0
HPO	HPO	CD	0
4	4	CD	0
,	,	,	0
3.0	3.0	FW	0
gm	gm	FW	0
/	/	FW	0
L	L	NNP	0
Tris	Tris	NNP	0
HCI	HCI	NNP	0
,	,	,	0
200	200	CD	0
mg	mg	CD	0
/	/	CD	0
L	L	NNP	0
CaCl	CaCl	NNP	0
2	2	CD	0
·	·	CD	0
2H	2H	CD	0
2	2	CD	0
O	O	NNP	0
,	,	,	0
100	100	CD	0
mg	mg	CD	0
/	/	CD	0
L	L	NNP	0
MgCl	MgCl	NNP	0
2	2	CD	0
·	·	CD	0
6H	6H	CD	0
2	2	CD	0
O	O	NNS	0
;	;	:	0
pH	pH	JJ	0
7.4	7.4	CD	0
)	)	-RRB-	0
.	.	.	0
The	The	DT	0
pituitary	pituitary	JJ	0
cell	cell	NN	0
culture	culture	NN	0
medium	medium	NN	0
was	was	VBD	0
aspirated	aspirated	JJ	0
and	and	CC	0
replaced	replaced	VBN	0
with	with	IN	0
the	the	DT	0
virus	virus	NN	0
solution	solution	NN	0
,	,	,	0
and	and	CC	0
the	the	DT	0
cells	cells	NNS	0
were	were	VBD	0
incubated	incubated	VBN	0
at	at	IN	0
37°C	37°C	CD	0
in	in	IN	0
a	a	DT	0
CO	CO	NNP	0
2	2	CD	0
incubator	incubator	NN	0
for	for	IN	0
approximately	approximately	RB	0
72	72	CD	0
h	h	NNS	0
.	.	.	0
Next	Next	JJ	B-NP
,	,	,	0
the	the	DT	0
cells	cells	NNS	0
were	were	VBD	0
collected	collected	VBN	0
by	by	IN	0
trypsinization	trypsinization	NN	B-NP
and	and	CC	0
counted	counted	VBN	0
using	using	VBG	0
a	a	DT	0
hemocytometer	hemocytometer	NN	B-NP
;	;	:	0
then	then	RB	0
,	,	,	0
they	they	PRP	0
were	were	VBD	0
checked	checked	VBN	0
for	for	IN	0
viability	viability	NN	0
using	using	VBG	0
trypan	trypan	JJ	B-NP
blue	blue	JJ	I-NP
[	[	-LRB-	0
31	31	CD	0
]	]	-RRB-	0
.	.	.	0
The	The	DT	0
cells	cells	NNS	0
were	were	VBD	0
replated	replated	VBN	0
for	for	IN	0
2	2	CD	0
h	h	NN	0
at	at	IN	0
37°C	37°C	CD	0
in	in	IN	0
DMEM	DMEM	NNP	B-NP
-0.1	-0.1	NNP	0
%	%	NN	0
bovine	bovine	JJ	B-NP
serum	serum	NN	I-NP
albumin	albumin	NN	I-NP
(	(	-LRB-	0
BSA	BSA	NNP	B-NP
)	)	-RRB-	0
and	and	CC	0
subjected	subjected	VBN	0
to	to	TO	0
fraction	fraction	NN	B-NP
determination	determination	NN	I-NP
x-gal	x-gal	JJ	I-NP
staining	staining	NN	I-NP
of	of	IN	0
cells	cells	NNS	0
infected	infected	VBN	0
by	by	IN	0
the	the	DT	0
virus	virus	NN	0
[	[	-LRB-	0
31	31	CD	0
]	]	-RRB-	0
,	,	,	0
or	or	CC	0
to	to	TO	0
stimulation	stimulation	VB	0
by	by	IN	0
GnRH-A	GnRH-A	JJ	B-NP
for	for	IN	0
measurement	measurement	NN	0
of	of	IN	0
LH	LH	NNP	B-NP
release	release	NN	I-NP
.	.	.	0
pituitary	pituitary	JJ	B-NP
cell	cell	NN	I-NP
gnrh-stimulated	gnrh-stimulated	NN	I-NP
lh	lh	NN	I-NP
secretion	secretion	VBD	I-NP
that	that	WDT	0
had	had	VBD	0
been	been	VBN	0
re-trypsinized	re-trypsinized	JJ	B-NP
72	72	CD	0
h	h	NN	0
after	after	IN	0
infection	infection	NN	B-NP
and	and	CC	0
then	then	RB	0
replated	replated	JJ	0
(	(	-LRB-	0
100,000	100,000	CD	0
cell	cell	NN	B-NP
/	/	VBP	I-NP
well	well	RB	I-NP
in	in	IN	0
a	a	DT	0
24-well	24-well	JJ	0
poly-L-lysine	poly-L-lysine	JJ	B-NP
coated	coated	JJ	0
plate	plate	NN	0
)	)	-RRB-	0
for	for	IN	0
a	a	DT	0
2	2	CD	0
h	h	CD	B-NP
preincubation	preincubation	NN	I-NP
were	were	VBD	0
subsequently	subsequently	RB	0
treated	treated	VBN	0
with	with	IN	0
a	a	DT	0
GnRH	GnRH	JJ	B-NP
agonist	agonist	NN	I-NP
(	(	-LRB-	0
1	1	CD	0
ml	ml	NN	0
of	of	IN	0
10	10	CD	0
-7M	-7M	FW	0
D-Ala	D-Ala	FW	0
6-	6-	FW	0
des	des	FW	0
Gly	Gly	FW	0
10-	10-	FW	0
GnRH	GnRH	FW	0
ethylamide	ethylamide	FW	0
;	;	:	0
GnRH-A	GnRH-A	NNP	B-NP
,	,	,	0
Sigma	Sigma	NNP	B-NP
,	,	,	0
St.	St.	NNP	B-NP
Louis	Louis	NNP	0
,	,	,	0
MO	MO	NNP	0
)	)	-RRB-	0
or	or	CC	0
a	a	DT	0
calcium	calcium	JJ	B-NP
ionophora	ionophora	NN	I-NP
(	(	-LRB-	0
A23187	A23187	NNP	0
,	,	,	0
Sigma	Sigma	NNP	B-NP
)	)	-RRB-	0
for	for	IN	0
3	3	CD	0
h	h	NNS	0
as	as	RB	0
described	described	VBN	0
by	by	IN	0
Conn	Conn	NNP	0
et	et	FW	0
al.	al.	FW	0
[	[	-LRB-	0
34	34	CD	0
]	]	-RRB-	0
.	.	.	0
The	The	DT	0
medium	medium	NN	0
was	was	VBD	0
removed	removed	VBN	0
and	and	CC	0
centrifuged	centrifuged	NN	0
at	at	IN	0
200	200	CD	0
×	×	CD	0
g	g	NN	0
for	for	IN	0
10	10	CD	0
min	min	NN	B-NP
to	to	TO	0
pellet	pellet	VB	0
any	any	DT	0
detached	detached	JJ	0
cells	cells	NNS	0
.	.	.	0
The	The	DT	0
supernatant	supernatant	JJ	B-NP
solution	solution	NN	I-NP
was	was	VBD	0
either	either	RB	0
used	used	VBN	0
immediately	immediately	RB	0
or	or	CC	0
stored	stored	VBD	0
at	at	IN	0
-20°C	-20°C	CD	0
prior	prior	JJ	0
to	to	TO	0
RIA	RIA	NNP	B-NP
.	.	.	0
lh	lh	NN	B-NP
ria	ria	NNP	I-NP
were	were	VBD	0
performed	performed	VBN	0
using	using	VBG	0
reagents	reagents	NNS	0
and	and	CC	0
instruction	instruction	NN	B-NP
provided	provided	VBN	0
by	by	IN	0
Dr.	Dr.	NNP	B-NP
A.	A.	NNP	0
F.	F.	NNP	0
Parlow	Parlow	NNP	0
on	on	IN	0
behalf	behalf	NN	0
of	of	IN	0
the	the	DT	0
National	National	NNP	B-NP
Hormone	Hormone	NNP	I-NP
and	and	CC	0
Pituitary	Pituitary	NNP	0
Program	Program	NNP	0
,	,	,	0
National	National	NNP	0
Institute	Institute	NNP	0
of	of	IN	0
Diabetes	Diabetes	NNP	0
and	and	CC	0
Digestive	Digestive	NNP	0
and	and	CC	0
Kidney	Kidney	NNP	0
Diseases	Diseases	NNP	0
,	,	,	0
NIH	NIH	NNP	B-NP
.	.	.	0
Rat	Rat	NNP	B-NP
LH	LH	NNP	I-NP
(	(	-LRB-	0
NIDDK-rLH-l-9	NIDDK-rLH-l-9	NNP	B-NP
)	)	-RRB-	0
was	was	VBD	0
radioiodinated	radioiodinated	CD	0
,	,	,	0
the	the	DT	0
LH	LH	NNP	B-NP
antiserum	antiserum	NN	I-NP
(	(	-LRB-	0
NIDDK-anti-rLH-S-11	NIDDK-anti-rLH-S-11	NNP	B-NP
)	)	-RRB-	0
was	was	VBD	0
prepared	prepared	VBN	0
in	in	IN	0
rabbits	rabbits	NN	0
,	,	,	0
and	and	CC	0
the	the	DT	0
reference	reference	NN	B-NP
standard	standard	NN	I-NP
was	was	VBD	0
NIDDK-rLH-RP3	NIDDK-rLH-RP3	CD	B-NP
.	.	.	0
The	The	DT	0
mean	mean	JJ	0
EC	EC	NNP	B-NP
50	50	CD	0
of	of	IN	0
the	the	DT	0
standard	standard	JJ	0
curves	curves	NNS	0
(	(	-LRB-	0
n	n	CD	0
=	=	SYM	0
10	10	CD	0
)	)	-RRB-	0
was	was	VBD	0
0.59	0.59	CD	0
ng	ng	NN	B-NP
with	with	IN	0
a	a	DT	0
coefficient	coefficient	NN	0
of	of	IN	0
variation	variation	NN	0
of	of	IN	0
4.4	4.4	CD	0
%	%	NN	0
.	.	.	0
GNRH-stimulated	GNRH-stimulated	NNP	0
3H-inositol	3H-inositol	NNP	0
phosphate	phosphate	JJ	0
accumulation	accumulation	NN	0
in	in	IN	0
pituitary	pituitary	JJ	B-NP
cell	cell	NN	I-NP
Total	Total	JJ	0
[	[	-LRB-	0
3H	3H	NNP	0
]	]	-RRB-	0
inositol	inositol	JJ	B-NP
phosphate	phosphate	JJ	I-NP
accumulation	accumulation	NN	I-NP
was	was	VBD	0
determined	determined	VBN	0
in	in	IN	0
[	[	-LRB-	0
3H	3H	NNP	0
]	]	-RRB-	0
myoinositol-labeled	myoinositol-labeled	JJ	B-NP
pituitary	pituitary	JJ	I-NP
cell	cell	NN	I-NP
as	as	RB	0
described	described	VBN	0
earlier	earlier	RBR	0
[	[	-LRB-	0
22	22	CD	0
]	]	-RRB-	0
.	.	.	0
At	At	IN	0
48	48	CD	0
h	h	NN	0
after	after	IN	0
pituitary	pituitary	JJ	B-NP
cell	cell	NN	I-NP
infection	infection	NN	I-NP
,	,	,	0
the	the	DT	0
incubation	incubation	JJ	B-NP
medium	medium	NN	I-NP
was	was	VBD	0
removed	removed	VBN	0
and	and	CC	0
replaced	replaced	VBN	0
with	with	IN	0
a	a	DT	0
balanced	balanced	JJ	0
salt	salt	NN	B-NP
solution	solution	NN	I-NP
(	(	-LRB-	0
10	10	CD	0
mm	mm	NN	B-NP
hepe	hepe	NN	I-NP
,	,	,	0
pH7.4	pH7.4	NNP	B-NP
,	,	,	0
135	135	CD	0
mM	mM	JJ	B-NP
NaCI	NaCI	NN	I-NP
,	,	,	0
4.5	4.5	CD	0
mM	mM	JJ	B-NP
KCL	KCL	NNP	I-NP
,	,	,	0
1.5	1.5	CD	0
mM	mM	JJ	0
CaCl	CaCl	JJ	B-NP
2	2	CD	0
,	,	,	0
0.5	0.5	CD	0
mM	mM	JJ	0
MgCL	MgCL	JJ	0
2	2	CD	0
,	,	,	0
1.0	1.0	CD	0
mM	mM	JJ	0
NaH	NaH	JJ	B-NP
2	2	CD	0
PO4	PO4	CD	B-NP
,	,	,	0
5.6	5.6	CD	0
mM	mM	JJ	B-NP
glucose	glucose	NN	I-NP
,	,	,	0
0.3	0.3	CD	0
%	%	NN	0
bovine	bovine	JJ	B-NP
serum	serum	NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
albumin	albumin	NN	I-NP
,	,	,	0
and	and	CC	0
10	10	CD	0
-9M	-9M	CD	0
estradiol	estradiol	CD	0
)	)	-RRB-	0
containing	containing	VBG	0
5	5	CD	0
μCi	μCi	NN	B-NP
of	of	IN	0
[	[	-LRB-	0
3H	3H	NNP	0
]	]	-RRB-	0
-myoinositol	-myoinositol	JJ	0
/	/	CD	0
ml	ml	NN	0
of	of	IN	0
medium	medium	NN	0
.	.	.	0
After	After	IN	0
a	a	DT	0
further	further	JJ	0
24	24	CD	0
h	h	NN	0
,	,	,	0
the	the	DT	0
pituitary	pituitary	JJ	B-NP
cell	cell	NN	I-NP
were	were	VBD	0
recovered	recovered	VBN	0
by	by	IN	0
trypinization	trypinization	NN	B-NP
,	,	,	0
counted	counted	VBN	0
,	,	,	0
and	and	CC	0
replated	replated	NN	0
in	in	IN	0
balanced	balanced	JJ	0
salt	salt	NN	B-NP
solution	solution	NN	I-NP
(	(	-LRB-	0
400,000	400,000	CD	0
-	-	:	0
500,000	500,000	CD	0
cell	cell	NN	B-NP
/	/	VBP	I-NP
well	well	RB	I-NP
in	in	IN	0
a	a	DT	0
24-well	24-well	JJ	0
plate	plate	NN	0
)	)	-RRB-	0
for	for	IN	0
a	a	DT	0
2	2	CD	0
h	h	CD	B-NP
preincubation	preincubation	NN	I-NP
.	.	.	0
Then	Then	RB	0
,	,	,	0
the	the	DT	0
cells	cells	NNS	0
were	were	VBD	0
stimulated	stimulated	VBN	0
with	with	IN	0
GnRH-A	GnRH-A	NNP	B-NP
(	(	-LRB-	0
10	10	CD	0
-7M	-7M	CD	0
for	for	IN	0
one	one	CD	0
hr	hr	CD	B-NP
)	)	-RRB-	0
in	in	IN	0
the	the	DT	0
presence	presence	NN	0
of	of	IN	0
5	5	CD	0
mM	mM	JJ	B-NP
LiCI.	LiCI.	NNP	I-NP
[	[	-LRB-	0
3H	3H	NNP	0
]	]	-RRB-	0
-inositol	-inositol	JJ	0
phosphate	phosphate	JJ	0
accumulation	accumulation	NN	0
in	in	IN	0
the	the	DT	0
cells	cells	NNS	0
was	was	VBD	0
then	then	RB	0
measured	measured	VBN	0
using	using	VBG	0
ion	ion	JJ	B-NP
exchange	exchange	NN	I-NP
chromatography	chromatography	VBZ	0
followed	followed	VBN	0
by	by	IN	0
liquid	liquid	JJ	B-NP
scintillation	scintillation	JJ	I-NP
spectroscopy	spectroscopy	NN	I-NP
[	[	-LRB-	0
22	22	CD	0
]	]	-RRB-	0
.	.	.	0
rgs3	rgs3	NN	B-NP
immunoblot	immunoblot	NN	I-NP
An	An	DT	0
antibody	antibody	NN	B-NP
to	to	TO	0
hexa-histidine-tagged	hexa-histidine-tagged	JJ	B-NP
human	human	JJ	0
RGS3T	RGS3T	NN	0
was	was	VBD	0
prepared	prepared	VBN	0
in	in	IN	0
chickens	chickens	NNS	0
.	.	.	0
RGS3T	RGS3T	NNP	0
[	[	-LRB-	0
24	24	CD	0
]	]	-RRB-	0
is	is	VBZ	0
the	the	DT	0
carboxy	carboxy	JJ	B-NP
terminal	terminal	NN	I-NP
206	206	CD	0
amino	amino	CD	0
acids	acids	NNS	0
(	(	-LRB-	0
a.a.	a.a.	NNP	0
314-519	314-519	NNP	0
)	)	-RRB-	0
of	of	IN	0
RGS3	RGS3	NNP	B-NP
and	and	CC	0
is	is	VBZ	0
represented	represented	VBN	0
by	by	IN	0
nt	nt	JJ	0
1227-1847	1227-1847	NN	0
of	of	IN	0
RGS3	RGS3	NNP	B-NP
cDNA	cDNA	NNP	I-NP
(	(	-LRB-	0
Genbank	Genbank	UH	B-NP
Accession	Accession	UH	I-NP
#	#	#	0
U27655	U27655	CD	0
)	)	-RRB-	0
.	.	.	0
To	To	TO	0
prepare	prepare	VB	0
hexa-histidine	hexa-histidine	JJ	B-NP
amino	amino	JJ	0
terminally-tagged	terminally-tagged	JJ	0
RGS3T	RGS3T	NN	0
,	,	,	0
we	we	PRP	0
modified	modified	VBD	0
RGS3T	RGS3T	NNP	0
cDNA	cDNA	NNP	0
[	[	-LRB-	0
24	24	CD	0
]	]	-RRB-	0
using	using	VBG	0
PCR	PCR	NNP	B-NP
with	with	IN	0
primers	primers	NNS	0
containing	containing	VBG	B-NP
restriction	restriction	NN	I-NP
site	site	NN	I-NP
(	(	-LRB-	0
the	the	DT	0
5	5	CD	0
'	'	POS	0
primer	primer	NN	0
incorporated	incorporated	VBN	0
a	a	DT	0
Bam	Bam	NNP	B-NP
HI	HI	NNP	I-NP
site	site	NN	I-NP
,	,	,	0
whereas	whereas	IN	0
the	the	DT	0
3	3	CD	0
'	'	POS	0
primer	primer	NN	0
bore	bore	VBD	0
an	an	DT	0
Nde	Nde	NNP	B-NP
1	1	CD	0
site	site	NN	0
)	)	-RRB-	0
.	.	.	0
The	The	DT	0
PCR	PCR	NNP	B-NP
product	product	NN	I-NP
was	was	VBD	0
then	then	RB	0
cloned	cloned	VBN	0
into	into	IN	0
the	the	DT	0
pET15b	pET15b	JJ	0
vector	vector	NN	0
which	which	WDT	0
carries	carries	VBZ	0
an	an	DT	0
N-terminal	N-terminal	JJ	B-NP
Histag	Histag	NNP	I-NP
sequence	sequence	VBD	I-NP
followed	followed	VBN	0
by	by	IN	0
BamH1	BamH1	NNP	B-NP
and	and	CC	0
Nde	Nde	NNP	B-NP
1	1	CD	0
cloning	cloning	CD	B-NP
site	site	NN	I-NP
(	(	-LRB-	0
Novagen	Novagen	NNP	B-NP
Inc.	Inc.	NNP	0
,	,	,	0
Madison	Madison	NNP	0
,	,	,	0
WI	WI	NNP	B-NP
)	)	-RRB-	0
.	.	.	0
The	The	DT	0
resulting	resulting	VBG	0
plasmid	plasmid	JJ	B-NP
DNA	DNA	NN	I-NP
was	was	VBD	0
nucleotide-sequenced	nucleotide-sequenced	JJ	B-NP
to	to	TO	0
confirm	confirm	VB	0
the	the	DT	0
presence	presence	NN	0
of	of	IN	0
RGS3T	RGS3T	NNP	0
cDNA	cDNA	NNP	0
.	.	.	0
The	The	DT	0
cDNA	cDNA	NN	B-NP
was	was	VBD	0
then	then	RB	0
used	used	VBN	0
to	to	TO	0
transform	transform	VB	0
bl21(de3)	bl21(de3)	NN	B-NP
strain	strain	NN	I-NP
e.	e.	NN	I-NP
coli	coli	NNS	I-NP
.	.	.	0
Protein	Protein	NN	B-NP
induction	induction	NN	I-NP
was	was	VBD	0
performed	performed	VBN	0
using	using	VBG	0
isopropyl-β-D-thiogalactopyranoside	isopropyl-β-D-thiogalactopyranoside	JJ	B-NP
(	(	-LRB-	0
IPTG	IPTG	NNP	0
)	)	-RRB-	0
as	as	RB	0
described	described	VBN	0
by	by	IN	0
Novagen	Novagen	NNP	B-NP
Inc	Inc	NNP	0
.	.	.	0
inclusion	inclusion	NN	B-NP
body	body	NN	I-NP
containing	containing	VBG	0
the	the	DT	0
protein	protein	NN	B-NP
were	were	VBD	0
prepared	prepared	VBN	0
and	and	CC	0
then	then	RB	0
solubized	solubized	VBN	0
in	in	IN	0
6	6	CD	0
M	M	NNP	0
guanidine	guanidine	NN	B-NP
.	.	.	0
The	The	DT	0
Histag	Histag	NNP	0
RGS3T	RGS3T	NNP	0
protein	protein	NN	0
was	was	VBD	0
purified	purified	VBN	0
on	on	IN	0
a	a	DT	0
Ni	Ni	NNP	0
2+resin	2+resin	NNP	0
using	using	VBG	0
a	a	DT	0
Pharmacia	Pharmacia	NNP	B-NP
Hi-Trap	Hi-Trap	NNP	I-NP
1	1	CD	0
ml	ml	JJ	B-NP
Chelating	Chelating	NNP	I-NP
Column	Column	NNP	I-NP
(	(	-LRB-	0
Pharmacia	Pharmacia	NNP	B-NP
Biotech	Biotech	NNP	I-NP
,	,	,	0
Piscataway	Piscataway	NNP	B-NP
,	,	,	0
neighbor	neighbor	NN	B-NP
joining	joining	VBG	I-NP
)	)	-RRB-	0
.	.	.	0
antibody	antibody	NN	B-NP
to	to	TO	0
Histag	Histag	NNP	0
RGS3T	RGS3T	NNP	0
protein	protein	NN	0
were	were	VBD	0
prepared	prepared	VBN	0
in	in	IN	0
chickens	chickens	NNS	0
(	(	-LRB-	0
ave	ave	NNP	B-NP
Labs	Labs	NNPS	0
,	,	,	0
Inc.	Inc.	NNP	0
,	,	,	0
Tigard	Tigard	NNP	B-NP
,	,	,	0
OR	OR	NNP	0
)	)	-RRB-	0
.	.	.	0
A	A	DT	0
chicken	chicken	NN	0
was	was	VBD	0
injected	injected	VBN	0
with	with	IN	0
145	145	CD	0
μg	μg	NN	B-NP
of	of	IN	0
RGS3T	RGS3T	CD	0
into	into	IN	0
the	the	DT	0
breast	breast	NN	0
muscle	muscle	NN	0
on	on	IN	0
four	four	CD	0
separate	separate	JJ	0
occasions	occasions	NNS	0
;	;	:	0
the	the	DT	0
first	first	JJ	0
injection	injection	NN	B-NP
was	was	VBD	0
in	in	IN	0
complete	complete	JJ	0
Freund	Freund	NNP	0
's	's	POS	0
adjuvant	adjuvant	NN	B-NP
,	,	,	0
whereas	whereas	IN	0
injections	injections	JJ	0
2-4	2-4	NN	0
were	were	VBD	0
made	made	VBN	0
in	in	IN	0
a	a	DT	0
1	1	CD	0
:	:	:	0
1	1	CD	0
dilution	dilution	NN	0
of	of	IN	0
complete	complete	JJ	0
and	and	CC	0
incomplete	incomplete	JJ	0
Freund	Freund	NNP	0
's	's	POS	0
adjuvant	adjuvant	NN	B-NP
.	.	.	0
One	One	CD	0
week	week	NN	B-NP
after	after	IN	0
the	the	DT	0
last	last	JJ	0
injection	injection	NN	B-NP
,	,	,	0
6	6	CD	0
immune	immune	JJ	0
eggs	eggs	NNS	0
were	were	VBD	0
collected	collected	VBN	0
,	,	,	0
and	and	CC	0
the	the	DT	0
IgY	IgY	JJ	B-NP
fraction	fraction	NN	I-NP
purified	purified	NN	I-NP
from	from	IN	0
the	the	DT	0
6	6	CD	0
eggs	eggs	NNS	0
as	as	IN	0
well	well	RB	0
as	as	RB	0
from	from	IN	0
3	3	CD	0
pre-immune	pre-immune	JJ	B-NP
egg	egg	NN	I-NP
collected	collected	VBN	0
from	from	IN	0
the	the	DT	0
same	same	JJ	0
hen	hen	NN	0
.	.	.	0
rgs3	rgs3	NN	B-NP
expression	expression	NN	I-NP
immunoblot	immunoblot	NN	I-NP
in	in	IN	0
pituitary	pituitary	JJ	B-NP
cell	cell	NN	I-NP
were	were	VBD	0
performed	performed	VBN	0
as	as	RB	0
described	described	VBN	0
previously	previously	RB	0
by	by	IN	0
us	us	PRP	0
[	[	-LRB-	0
22	22	CD	0
23	23	CD	0
]	]	-RRB-	0
.	.	.	0
In	In	IN	0
brief	brief	JJ	0
,	,	,	0
rat	rat	JJ	0
pituitary	pituitary	JJ	B-NP
cell	cell	NN	I-NP
at	at	IN	0
72	72	CD	0
h	h	NN	0
after	after	IN	0
adeno-RGS3	adeno-RGS3	CD	B-NP
infection	infection	NN	I-NP
(	(	-LRB-	0
5	5	CD	0
M.O.I.	M.O.I.	CD	B-NP
)	)	-RRB-	0
were	were	VBD	0
collected	collected	VBN	0
by	by	IN	0
trypsinization	trypsinization	NN	B-NP
,	,	,	0
homogenized	homogenized	NN	B-NP
,	,	,	0
and	and	CC	0
a	a	DT	0
protein	protein	NN	B-NP
determination	determination	NN	I-NP
made	made	VBD	0
.	.	.	0
Fifty	Fifty	JJ	0
μg	μg	JJ	B-NP
protein	protein	NN	I-NP
sample	sample	NN	I-NP
were	were	VBD	0
heated	heated	VBN	0
in	in	IN	0
containing	containing	VBG	B-NP
β-mercaptoethanol	β-mercaptoethanol	JJ	I-NP
sds-page	sds-page	NN	I-NP
sample	sample	NN	I-NP
buffer	buffer	NN	I-NP
and	and	CC	0
then	then	RB	0
electrophoresed	electrophoresed	VBN	0
on	on	IN	0
a	a	DT	0
10	10	CD	0
%	%	NN	0
SDS-polyacrylamide	SDS-polyacrylamide	JJ	B-NP
gel	gel	NN	I-NP
.	.	.	0
Separated	Separated	JJ	0
proteins	proteins	NNS	0
were	were	VBD	0
electroblotted	electroblotted	VBN	0
onto	onto	IN	0
nylon	nylon	JJ	0
membranes	membranes	NNS	0
(	(	-LRB-	0
Millipore	Millipore	NNP	B-NP
Corp.	Corp.	NNP	0
,	,	,	0
Bedford	Bedford	NNP	0
,	,	,	0
MA	MA	NNP	0
)	)	-RRB-	0
which	which	WDT	0
were	were	VBD	0
then	then	RB	0
incubated	incubated	VBN	0
for	for	IN	0
2	2	CD	0
h	h	NN	0
in	in	IN	0
a	a	DT	0
blocking	blocking	JJ	0
solution	solution	NN	B-NP
containing	containing	VBG	0
5	5	CD	0
%	%	NN	0
non-fat	non-fat	JJ	B-NP
dry	dry	JJ	0
milk	milk	NN	0
in	in	IN	0
phosphate	phosphate	JJ	B-NP
buffered	buffered	NNS	0
saline	saline	VBP	0
containing	containing	VBG	0
0.02	0.02	CD	0
%	%	NN	0
Tween-20	Tween-20	NN	B-NP
.	.	.	0
The	The	DT	0
primary	primary	JJ	B-NP
antibody	antibody	NN	I-NP
(	(	-LRB-	0
chicken	chicken	NN	B-NP
IgY	IgY	NN	I-NP
,	,	,	0
62.5	62.5	CD	0
μg	μg	CD	B-NP
/	/	CD	I-NP
ml	ml	CD	I-NP
)	)	-RRB-	0
was	was	VBD	0
diluted	diluted	VBN	0
in	in	IN	0
blocking	blocking	VBG	B-NP
solution	solution	NN	I-NP
and	and	CC	0
incubated	incubated	JJ	0
overnight	overnight	JJ	0
at	at	IN	0
4°C	4°C	CD	0
with	with	IN	0
the	the	DT	0
nylon	nylon	JJ	0
membrane	membrane	NN	0
.	.	.	0
Blots	Blots	NNP	0
were	were	VBD	0
then	then	RB	0
incubated	incubated	VBN	0
for	for	IN	0
2	2	CD	0
h	h	NN	0
at	at	IN	0
room	room	NN	B-NP
temperature	temperature	NN	I-NP
in	in	IN	0
alkaline	alkaline	JJ	B-NP
phosphatase-conjugated	phosphatase-conjugated	NN	I-NP
goat	goat	NN	I-NP
anti-chicken	anti-chicken	NN	I-NP
IgY	IgY	NN	I-NP
(	(	-LRB-	0
0.1	0.1	CD	0
μg	μg	CD	B-NP
/	/	CD	I-NP
ml	ml	NN	I-NP
diluted	diluted	VBN	0
in	in	IN	0
blocking	blocking	VBG	B-NP
solution	solution	NN	I-NP
;	;	:	0
ave	ave	NNP	B-NP
Labs	Labs	NNPS	0
,	,	,	0
Tigard	Tigard	NNP	B-NP
,	,	,	0
OR	OR	NNP	0
)	)	-RRB-	0
.	.	.	0
Color	Color	NN	B-NP
development	development	NN	I-NP
was	was	VBD	0
achieved	achieved	VBN	0
by	by	IN	0
incubating	incubating	VBG	0
the	the	DT	0
membrane	membrane	NN	0
in	in	IN	0
substrate	substrate	NNS	0
[	[	-LRB-	0
(	(	-LRB-	0
5-bromo-4-chloro-3-indolyl	5-bromo-4-chloro-3-indolyl	FW	0
phosphate-nitrobluetetra-zolium	phosphate-nitrobluetetra-zolium	FW	0
chloride	chloride	FW	0
)	)	-RRB-	0
(	(	-LRB-	0
BCIP-NBT	BCIP-NBT	NNP	B-NP
)	)	-RRB-	0
]	]	-RRB-	0
.	.	.	0
lh	lh	NN	B-NP
content	content	JJ	I-NP
assay	assay	NN	I-NP
in	in	IN	0
lh	lh	NN	B-NP
ria	ria	NNP	I-NP
measurement	measurement	NN	I-NP
pituitary	pituitary	JJ	I-NP
cell	cell	NN	I-NP
of	of	IN	0
cell	cell	NN	0
contents	contents	NNS	0
,	,	,	0
1	1	CD	0
×	×	CD	0
10	10	CD	0
5anterior	5anterior	CD	0
pituitary	pituitary	CD	0
cells	cells	NNS	0
infected	infected	VBN	0
,	,	,	0
or	or	CC	0
not	not	RB	0
,	,	,	0
72	72	CD	0
h	h	NNS	0
previously	previously	RB	0
with	with	IN	0
adeno-RGS3	adeno-RGS3	NNP	B-NP
or	or	CC	0
adeno-βgal	adeno-βgal	NNP	B-NP
were	were	VBD	0
trypsinized	trypsinized	JJ	0
and	and	CC	0
plated	plated	NN	0
for	for	IN	0
2	2	CD	0
h	h	NN	B-NP
.	.	.	I-NP
LH	LH	NNP	I-NP
was	was	VBD	0
extracted	extracted	VBN	0
from	from	IN	0
the	the	DT	0
cells	cells	NNS	0
[	[	-LRB-	0
36	36	CD	0
]	]	-RRB-	0
by	by	IN	0
removing	removing	VBG	0
and	and	CC	0
discarding	discarding	VBG	0
the	the	DT	0
medium	medium	NN	0
and	and	CC	0
adding	adding	VBG	0
1	1	CD	0
ml	ml	CD	0
extraction	extraction	JJ	B-NP
buffer	buffer	NN	I-NP
(	(	-LRB-	0
150	150	CD	0
mM	mM	JJ	B-NP
NaCI	NaCI	NN	I-NP
,	,	,	0
50	50	CD	0
mm	mm	NN	B-NP
tri	tri	NNP	I-NP
,	,	,	0
5	5	CD	0
mM	mM	JJ	B-NP
EDTA	EDTA	NNP	I-NP
,	,	,	0
and	and	CC	0
1	1	CD	0
mM	mM	JJ	B-NP
bacitracin	bacitracin	NN	I-NP
,	,	,	0
pH	pH	JJ	0
7.4	7.4	CD	0
)	)	-RRB-	0
followed	followed	VBD	0
by	by	IN	0
freeze-thawing	freeze-thawing	JJ	0
twice	twice	RB	0
.	.	.	0
After	After	IN	0
centrifugation	centrifugation	NN	B-NP
,	,	,	0
the	the	DT	0
supernatant	supernatant	NN	B-NP
was	was	VBD	0
removed	removed	VBN	0
and	and	CC	0
subjected	subjected	VBN	0
to	to	TO	0
LH	LH	NNP	B-NP
RIA	RIA	NNP	I-NP
as	as	RB	0
described	described	VBN	0
above	above	IN	0
.	.	.	0
gnrh	gnrh	NN	B-NP
receptor	receptor	NN	I-NP
measurement	measurement	NN	I-NP
by	by	IN	0
receptor	receptor	NN	B-NP
radioassay	radioassay	NN	I-NP
(	(	-LRB-	0
RRA	RRA	NNP	B-NP
)	)	-RRB-	0
About	About	IN	0
3	3	CD	0
×	×	CD	0
10	10	CD	0
6pituitary	6pituitary	CD	0
cells	cells	NNS	0
infected	infected	VBN	0
,	,	,	0
or	or	CC	0
not	not	RB	0
,	,	,	0
72	72	CD	0
h	h	NNS	0
previously	previously	RB	0
with	with	IN	0
adeno-βgal	adeno-βgal	JJ	B-NP
or	or	CC	0
adeno-RGS3	adeno-RGS3	NNP	B-NP
were	were	VBD	0
trypsinized	trypsinized	CD	0
,	,	,	0
and	and	CC	0
cell	cell	NN	0
membranes	membranes	VBZ	0
containing	containing	VBG	0
the	the	DT	0
gnrh	gnrh	NN	B-NP
receptor	receptor	NN	I-NP
were	were	VBD	0
prepared	prepared	VBN	0
by	by	IN	0
placing	placing	VBG	0
the	the	DT	0
cells	cells	NNS	0
in	in	IN	0
a	a	DT	0
Dounce	Dounce	JJ	B-NP
homogenizer	homogenizer	NN	I-NP
(	(	-LRB-	0
konte	konte	NN	B-NP
Co.	Co.	NNP	0
,	,	,	0
Vineland	Vineland	NNP	B-NP
,	,	,	0
neighbor	neighbor	NN	B-NP
joining	joining	VBG	I-NP
)	)	-RRB-	0
and	and	CC	0
disrupting	disrupting	VBG	0
them	them	PRP	0
with	with	IN	0
30	30	CD	0
strokes	strokes	NNS	0
of	of	IN	0
the	the	DT	0
pestle	pestle	NN	0
.	.	.	0
The	The	DT	0
cell	cell	NN	0
membranes	membranes	NNS	0
were	were	VBD	0
pelleted	pelleted	VBN	0
by	by	IN	0
centrifugation	centrifugation	NN	B-NP
at	at	IN	0
26,000	26,000	CD	0
×	×	CD	0
g	g	NNS	0
and	and	CC	0
then	then	RB	0
resuspended	resuspended	VBN	0
in	in	IN	0
10	10	CD	0
mM	mM	JJ	0
Tris	Tris	JJ	B-NP
buffer	buffer	NN	I-NP
.	.	.	0
The	The	DT	0
GnRH	GnRH	JJ	B-NP
RRA	RRA	NN	I-NP
on	on	IN	0
the	the	DT	0
membranes	membranes	NN	0
was	was	VBD	0
performed	performed	VBN	0
as	as	RB	0
described	described	VBN	0
previously	previously	RB	0
[	[	-LRB-	0
22	22	CD	0
23	23	CD	0
]	]	-RRB-	0
.	.	.	0
Cell	Cell	NN	0
membranes	membranes	NNS	0
and	and	CC	0
1	1	CD	0
×	×	CD	0
10	10	CD	0
5cpm	5cpm	CD	0
[	[	-LRB-	0
125I	125I	NNP	0
]	]	-RRB-	0
GnRH-A	GnRH-A	NNP	B-NP
were	were	VBD	0
incubated	incubated	VBN	0
at	at	IN	0
0°C	0°C	CD	0
for	for	IN	0
90	90	CD	0
min	min	NN	B-NP
.	.	.	0
Nonspecific	Nonspecific	JJ	B-NP
binding	binding	NN	I-NP
was	was	VBD	0
determined	determined	VBN	0
as	as	IN	0
counts	counts	NNS	0
per	per	IN	0
min	min	VBG	B-NP
bound	bound	VBN	0
in	in	IN	0
the	the	DT	0
presence	presence	NN	0
of	of	IN	0
10	10	CD	0
-6M	-6M	CD	0
unlabeled	unlabeled	JJ	0
GnRH-A	GnRH-A	NN	B-NP
.	.	.	0
Bound	Bound	NNP	0
and	and	CC	0
free	free	JJ	0
[	[	-LRB-	0
125I	125I	NNP	0
]	]	-RRB-	0
GnRH-A	GnRH-A	NNP	B-NP
were	were	VBD	0
separated	separated	VBN	0
by	by	IN	0
filtration	filtration	NN	0
.	.	.	0
The	The	DT	0
filters	filters	NNS	0
were	were	VBD	0
counted	counted	VBN	0
by	by	IN	0
γ-scintillation	γ-scintillation	JJ	B-NP
spectrometry	spectrometry	NN	I-NP
.	.	.	0
Data	Data	NNP	0
analysis	analysis	NN	0
The	The	DT	0
results	results	NNS	0
are	are	VBP	0
presented	presented	VBN	0
as	as	IN	0
the	the	DT	0
mean	mean	JJ	0
±	±	NNP	0
SEM	SEM	NNP	B-NP
of	of	IN	0
at	at	IN	0
least	least	JJS	0
three	three	CD	0
independent	independent	JJ	0
experiments	experiments	NNS	0
unless	unless	IN	0
indicated	indicated	VBN	0
otherwise	otherwise	RB	0
.	.	.	0
The	The	DT	0
statistical	statistical	JJ	B-NP
test	test	NN	I-NP
were	were	VBD	0
one-way	one-way	JJ	B-NP
or	or	CC	0
two-way	two-way	JJ	0
analyses	analyses	NNS	0
of	of	IN	0
variance	variance	NN	0
with	with	IN	0
significant	significant	JJ	0
differences	differences	NNS	0
(	(	-LRB-	0
p	p	CD	0
<	<	SYM	0
0.05	0.05	CD	0
)	)	-RRB-	0
identified	identified	VBN	0
by	by	IN	0
the	the	DT	0
Student	Student	NN	0
-	-	:	0
newman-keul	newman-keul	NN	B-NP
method	method	NN	0
.	.	.	0
Statistical	Statistical	JJ	B-NP
analysis	analysis	NN	I-NP
was	was	VBD	0
performed	performed	VBN	0
using	using	VBG	0
Sigma	Sigma	NNP	B-NP
Stat	Stat	NNP	I-NP
Statistical	Statistical	NNP	I-NP
Software	Software	NNP	I-NP
for	for	IN	0
Windows	Windows	NNP	0
(	(	-LRB-	0
Jandel	Jandel	NNP	B-NP
Scientific	Scientific	NNP	I-NP
,	,	,	0
San	San	NNP	0
Rafael	Rafael	NNP	0
,	,	,	0
CA	CA	NNP	B-NP
)	)	-RRB-	0
.	.	.	0
